data_2mic_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mic _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 CA-C-O 120.804 0.251 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.53 -36.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -49.29 47.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.43 -28.3 69.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 m -77.13 -52.27 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.13 -37.96 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.92 -57.26 7.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.57 -38.62 55.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.41 20.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 t -57.93 -40.71 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.86 -58.5 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.06 -60.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.33 -48.18 54.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 tp -51.7 -61.8 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.37 -32.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.56 69.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -66.41 -34.97 79.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.3 -39.68 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.99 64.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.98 -26.38 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.57 -45.98 15.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.799 0.249 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.51 -36.18 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.43 -49.48 41.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.57 -28.25 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.4 m -77.02 -51.97 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.5 -38.12 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -57.67 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.51 -38.79 55.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.64 18.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 27.4 t -57.44 -40.13 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.55 -58.52 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.75 -61.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.18 -48.52 52.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.896 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.27 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -51.31 -27.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.93 -49.41 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.72 -31.14 71.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -49.19 22.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.955 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.0 mt -65.79 -38.62 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.81 8.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.23 -45.13 61.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -54.52 39.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.3 t -55.07 -48.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.149 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.44 -53.24 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.69 -61.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.83 49.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -55.56 30.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.65 -33.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -27.51 60.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -74.01 -45.38 50.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.42 -47.42 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -59.84 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -51.92 -30.39 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.29 -42.85 35.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 2.9 p -51.39 -27.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.85 -49.44 70.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 t -65.8 -31.59 72.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -49.07 25.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.73 -38.22 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -57.72 9.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.86 62.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.27 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -54.97 -50.05 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.07 -52.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.64 -63.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.05 89.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.864 0.277 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -50.26 -28.12 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.39 -49.39 71.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -64.09 -32.45 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.9 m -74.59 -50.83 16.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.55 -37.84 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -56.7 13.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.41 -47.56 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.23 -53.25 53.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.139 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.74 -51.65 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -55.61 -55.26 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 HG12 ' B' ' 121' ' ' VAL . 95.1 t -50.56 -60.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.84 -39.78 48.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -57.17 13.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.425 HG22 HG12 ' B' ' 122' ' ' VAL . 62.9 t -57.9 -32.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.98 -27.01 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -74.54 -45.73 43.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -73.13 -46.31 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -61.18 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -52.17 -52.21 53.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -53.71 -37.28 63.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.819 0.258 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 p -50.24 -28.27 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.26 -49.36 72.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.03 -32.47 74.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.0 m -74.53 -50.94 16.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 55.8 mt -65.32 -37.43 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.03 -56.41 15.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.46 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.57 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 34.6 t -56.52 -50.91 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 22' ' ' VAL . 61.4 t -56.66 -53.45 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 25' ' ' VAL . 99.0 t -51.06 -63.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.55 -42.93 85.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.82 0.258 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -49.66 -28.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -68.87 -49.93 54.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -63.43 -32.33 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 m -73.56 -53.6 10.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.34 -36.94 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.154 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.42 -56.46 10.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.88 -45.6 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -55.22 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.92 -44.68 78.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.097 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.7 -59.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.34 -63.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.67 -41.88 51.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.572 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -61.61 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.85 -30.01 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.53 50.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -74.86 -43.79 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.4 -46.56 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.07 -59.53 5.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -51.65 -40.1 59.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -29.16 64.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.808 0.253 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.62 -28.66 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.159 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -67.9 -50.24 57.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.23 -33.84 76.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -69.46 -53.84 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 47.0 mt -60.18 -31.84 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.142 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -64.71 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.48 -40.56 37.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.59 -54.41 46.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.46 -49.16 83.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.087 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.07 -56.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.7 t -49.03 -60.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.66 -39.1 45.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.86 0.275 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.43 -27.89 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.11 -49.43 72.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.08 -32.22 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -51.58 14.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.825 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.4 mt -62.65 -37.82 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -55.63 19.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.59 -48.01 57.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -52.89 62.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.03 -30.9 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.072 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.55 -57.69 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.054 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.69 -57.63 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.76 -49.32 66.63 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.0 tp -51.91 -61.28 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.362 . . . . 0.0 110.899 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -51.43 -31.67 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -39.38 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.56 -35.94 82.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.58 -39.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.88 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.41 -30.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -71.38 -58.88 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.807 0.253 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 p -50.52 -27.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.06 -49.38 72.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.03 -32.51 74.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -51.34 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 36.4 mt -62.69 -37.93 80.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.19 -56.0 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.34 -48.1 55.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.05 -52.36 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.78 -31.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.07 -58.19 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -51.58 -57.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.187 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -48.73 67.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.549 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.792 0.247 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.88 -29.15 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.32 -49.31 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.23 -33.19 75.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.21 -50.77 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.11 -38.89 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.0 -56.98 13.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.34 -48.26 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.82 -53.1 43.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 t -54.36 -51.56 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.07 -47.84 85.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.82 -63.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.94 62.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -52.53 -60.48 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.48 -37.91 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -26.86 67.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.16 -47.21 20.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.72 -32.13 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.22 3.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.5 -28.15 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -68.98 -58.77 3.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 CA-C-O 120.822 0.259 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.75 -29.04 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.189 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.45 -49.43 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.29 -33.02 74.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -73.36 -50.64 20.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.37 -38.68 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -57.23 12.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.11 -48.49 61.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.11 41.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 t -54.43 -51.45 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.27 -47.71 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 96.8 t -53.96 -63.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.084 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.63 -51.05 61.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.173 0 CA-C-O 120.885 0.285 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.29 -28.28 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -49.58 69.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -29.47 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -74.92 -50.52 16.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -66.47 -38.18 81.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -56.08 10.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.4 -44.1 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.36 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -52.66 -35.16 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.4 -50.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.76 -58.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.56 -56.24 26.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.472 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.92 -61.73 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.943 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.59 -32.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.23 -32.77 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -73.61 -34.37 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.24 -54.27 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.12 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -44.73 -58.98 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -37.91 64.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.854 0.272 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.8 p -50.97 -28.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -49.42 74.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -31.73 72.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -73.06 -49.61 27.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 33.4 mt -62.24 -33.98 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -58.52 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.04 -43.04 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -57.71 11.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 46.4 t -53.59 -35.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -72.05 -51.39 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.175 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.35 -58.96 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.7 -56.28 25.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.222 0 CA-C-O 120.808 0.253 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.07 -28.3 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -68.75 -49.94 54.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.02 -32.23 73.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -73.24 -52.84 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mt -65.5 -36.55 77.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -57.25 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.52 -49.13 56.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.03 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -54.51 -53.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.98 -51.86 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.49 -58.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.44 58.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -54.5 43.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 0.0 110.976 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.17 -32.75 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.76 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -76.64 -45.2 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.85 -53.58 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.81 -61.22 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -52.43 -29.99 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -75.97 -36.96 59.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.85 0.271 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.98 -28.47 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.82 -50.29 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -69.95 -53.43 17.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 47.0 mt -60.98 -32.64 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -64.29 0.9 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.41 -45.94 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -54.22 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.9 -52.57 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.88 -44.08 85.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.5 -63.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.21 95.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.848 0.27 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.76 -21.89 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.74 -49.78 28.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -27.48 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.8 m -77.14 -51.5 10.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.9 mt -67.18 -40.56 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.5 -55.25 18.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.45 -47.82 56.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.07 -56.54 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.5 t -53.15 -35.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.36 -45.91 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.4 ' HA ' HG11 ' B' ' 122' ' ' VAL . 57.8 t -55.1 -59.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.45 58.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.1 tp -51.7 -61.94 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.377 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.25 -34.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.04 -29.72 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -75.82 -35.06 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.06 -45.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.92 -61.18 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -44.76 -54.84 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.1 -44.19 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.768 0.237 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.69 -26.69 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.45 -49.46 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -30.73 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 52.8 m -73.66 -50.52 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.62 -35.93 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -56.88 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.19 -47.26 54.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.74 -56.5 18.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 46.0 t -52.53 -35.67 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 93.8 t -73.53 -44.92 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 22' ' ' VAL . 61.0 t -55.36 -59.88 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.11 -50.17 70.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.917 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.849 0.27 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.37 -28.94 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -60.32 -46.86 88.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.74 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -46.08 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.791 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.3 mt -63.27 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tp -53.76 -60.2 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.05 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.64 63.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.04 -51.52 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.164 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 HG13 HG21 ' B' ' 122' ' ' VAL . 48.7 t -57.81 -48.34 83.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.68 -63.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.44 -51.78 56.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.544 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -52.0 -60.59 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.955 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.22 -38.05 66.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.99 67.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -77.02 -47.31 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.5 -32.22 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.03 -61.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -54.62 -30.25 54.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -80.29 -51.73 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.841 0.267 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.0 p -49.46 -29.26 3.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.44 -49.6 75.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.967 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' CYS . . . . . 0.486 ' HA ' ' CD2' ' B' ' 117' ' ' LEU . 0.1 OUTLIER -68.72 -42.04 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.857 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -37.52 85.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 45.0 mt -75.24 -55.29 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' B' ' 114' ' ' CYS . 3.5 pp -58.48 -39.34 79.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.57 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.47 68.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 41.7 t -63.14 -51.33 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.71 -48.73 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.481 HG21 HG13 ' A' ' 21' ' ' VAL . 97.3 t -53.55 -63.49 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.37 -51.77 56.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.93 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.2 p -82.77 -35.39 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 52.93 51.66 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.92 5.84 83.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.12 34.83 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.143 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.2 t -88.31 -25.13 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.3 74.24 0.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.77 89.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -176.91 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.501 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 3.9 mt -47.12 -58.62 6.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.3 Cg_endo -69.69 52.54 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.7 2.266 . . . . 0.0 112.387 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.53 -36.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -49.29 47.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.43 -28.3 69.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 m -77.13 -52.27 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.13 -37.96 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.92 -57.26 7.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.57 -38.62 55.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.41 20.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 t -57.93 -40.71 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.86 -58.5 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -52.06 -60.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.33 -48.18 54.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.9 tp -51.7 -61.8 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.37 -32.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.56 69.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -66.41 -34.97 79.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.3 -39.68 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.99 64.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.98 -26.38 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.57 -45.98 15.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -64.32 -30.9 71.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -86.25 -17.28 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -55.22 -25.87 35.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.57 -34.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.66 146.6 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.39 175.18 7.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.9 -60.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 55.99 65.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? 61.01 97.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.869 0.366 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 81.2 p -83.06 -36.13 25.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 52.18 51.39 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.16 7.74 79.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.56 29.96 6.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 2.2 t -94.71 -19.38 20.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.18 83.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.46 93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -62.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.507 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 3.6 mt -50.33 -58.71 8.9 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 111.132 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.4 Cg_endo -69.81 53.09 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.319 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -79.51 -36.18 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.43 -49.48 41.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.57 -28.25 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.4 m -77.02 -51.97 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.5 -38.12 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.108 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.71 -57.67 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.51 -38.79 55.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.64 18.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 27.4 t -57.44 -40.13 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.55 -58.52 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 97.3 t -51.75 -61.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.18 -48.52 52.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 tp -51.7 -61.85 1.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.44 -32.88 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.107 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.37 -35.07 79.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.21 -39.74 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.155 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.95 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.87 -26.34 66.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.95 -45.81 14.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -63.94 -29.92 71.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -86.87 -16.46 35.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.02 -25.5 44.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.48 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.83 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.92 146.86 7.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 174.79 7.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -96.09 -60.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 56.25 65.51 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? 61.19 97.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.87 0.367 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.475 HG22 HG22 ' B' ' 102' ' ' THR . 0.2 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.156 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.68 -74.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.02 27.84 23.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -29.71 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.84 131.66 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -122.22 -65.47 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.66 24.41 5.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.7 mp -117.01 -33.76 4.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 mt -70.01 -57.19 6.47 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.539 0.685 . . . . 0.0 111.156 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.2 Cg_endo -69.75 -45.29 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 p -51.31 -27.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.93 -49.41 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.72 -31.14 71.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -49.19 22.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.955 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.0 mt -65.79 -38.62 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.81 8.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.23 -45.13 61.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -54.52 39.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.3 t -55.07 -48.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.149 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.44 -53.24 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.9 t -50.69 -61.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.83 49.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.49 -55.56 30.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.65 -33.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -27.51 60.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -74.01 -45.38 50.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.42 -47.42 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -59.84 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -51.92 -30.39 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.29 -42.85 35.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -59.91 -26.24 65.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.413 ' CE2' ' CE1' ' B' ' 130' ' ' PHE . 75.4 m95 -79.35 -21.31 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -40.52 70.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 m -94.26 9.27 38.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -93.03 43.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.56 -170.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.447 ' NE2' ' HG3' ' B' ' 138' ' ' GLN . 13.6 tm0? -132.73 111.04 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -106.34 101.52 10.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.56 103.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 41.1 mtt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.892 0.377 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 2' ' ' THR . 0.2 OUTLIER -136.91 -172.66 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.173 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -74.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.01 27.91 23.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -29.71 19.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 131.68 43.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -122.27 -65.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.82 24.48 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 10.6 mp -117.03 -33.6 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 2.5 mt -70.08 -57.34 6.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.2 Cg_endo -69.81 -45.0 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.297 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 2.9 p -51.39 -27.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.85 -49.44 70.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 t -65.8 -31.59 72.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -49.07 25.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.73 -38.22 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -57.72 9.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.24 -45.86 62.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.116 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.27 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -54.97 -50.05 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.07 -52.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.64 -63.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.05 89.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -56.39 18.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.987 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.1 t -57.83 -32.44 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.47 60.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -73.52 -45.08 55.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.38 -47.35 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.12 -59.88 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.413 ' CE1' ' CE2' ' A' ' 33' ' ' TRP . 18.0 t80 -51.89 -30.22 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -42.74 39.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -59.45 -26.35 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -79.19 -21.27 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -40.52 70.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 3.0 m -94.03 9.52 37.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -92.98 43.93 1.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.84 -170.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . 0.447 ' HG3' ' NE2' ' A' ' 38' ' ' GLN . 13.5 tm0? -132.66 111.22 11.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.932 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -106.35 101.77 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 103.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.855 0.36 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.99 110.66 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.143 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -144.24 40.04 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.75 -20.28 63.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.16 41.83 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.156 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.72 -46.78 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 50.13 27.97 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.56 32.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.58 -74.92 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mt -71.58 -57.75 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.647 0.737 . . . . 0.0 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.6 Cg_endo -69.77 -5.71 16.87 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.746 2.297 . . . . 0.0 112.335 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.8 p -50.26 -28.12 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.39 -49.39 71.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -64.09 -32.45 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.9 m -74.59 -50.83 16.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.55 -37.84 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -56.7 13.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.41 -47.56 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.23 -53.25 53.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.139 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.4 t -57.74 -51.65 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.1 t -55.61 -55.26 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 HG12 ' B' ' 121' ' ' VAL . 95.1 t -50.56 -60.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.84 -39.78 48.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -57.17 13.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.425 HG22 HG12 ' B' ' 122' ' ' VAL . 62.9 t -57.9 -32.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.98 -27.01 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -74.54 -45.73 43.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -73.13 -46.31 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -61.18 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -52.17 -52.21 53.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -53.71 -37.28 63.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -57.39 -26.03 60.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -17.46 34.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.66 -45.6 78.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 p -86.69 -37.66 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -51.7 -30.5 22.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 94.85 3.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.63 70.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -169.27 86.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.31 84.85 2.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.871 0.367 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.01 110.84 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -144.08 40.02 1.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.72 -20.53 63.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.487 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.17 41.6 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 111.18 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.91 -46.96 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 50.21 27.87 2.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.31 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.57 -74.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.525 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 2.1 mt -71.62 -57.79 4.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.711 0.767 . . . . 0.0 111.204 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.2 Cg_endo -69.78 -5.69 16.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.645 2.23 . . . . 0.0 112.39 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 p -50.24 -28.27 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.26 -49.36 72.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.03 -32.47 74.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.0 m -74.53 -50.94 16.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 55.8 mt -65.32 -37.43 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.03 -56.41 15.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.46 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.57 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 34.6 t -56.52 -50.91 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . 0.451 HG12 HG22 ' A' ' 22' ' ' VAL . 61.4 t -56.66 -53.45 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 25' ' ' VAL . 99.0 t -51.06 -63.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.55 -42.93 85.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -58.29 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.43 -31.62 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.0 -27.38 57.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -74.53 -46.15 41.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mt -73.28 -46.06 51.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.118 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.69 -61.03 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -52.1 -52.48 51.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -54.22 -37.58 64.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -57.51 -25.62 60.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.825 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.36 -12.55 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -69.74 -70.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 1.8 p -106.17 -45.09 4.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.68 -30.36 21.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 94.8 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.23 70.79 0.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -169.11 86.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 84.85 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.11 138.73 12.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -72.41 138.17 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.62 -20.02 9.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 63.62 25.27 14.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.343 . . . . 0.0 111.155 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 136.93 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.201 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.26 88.5 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.16 22.93 13.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.14 -39.23 13.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.517 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.3 mt -71.36 -57.74 4.32 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 0.0 111.181 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.3 Cg_endo -69.8 -4.93 15.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -49.66 -28.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -68.87 -49.93 54.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -63.43 -32.33 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 m -73.56 -53.6 10.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.34 -36.94 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.154 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -66.42 -56.46 10.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.88 -45.6 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -55.22 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -55.92 -44.68 78.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.097 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.7 -59.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.8 t -51.34 -63.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.67 -41.88 51.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.572 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -61.61 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.85 -30.01 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.53 50.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -74.86 -43.79 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.4 -46.56 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.07 -59.53 5.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -51.65 -40.1 59.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -29.16 64.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -73.51 -41.36 63.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -86.19 -16.45 37.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -56.97 -45.54 82.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.0 p -152.3 -40.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -50.01 158.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.72 -32.04 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -162.2 131.72 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -127.56 -74.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.82 -169.71 3.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.838 0.351 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.29 138.72 12.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -72.28 138.08 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.77 -20.48 8.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.46 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.8 m 63.32 25.73 14.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 0.0 111.213 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 137.56 44.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.41 88.64 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.14 22.96 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.1 -39.08 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.515 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 5.3 mt -71.48 -57.63 4.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.672 0.749 . . . . 0.0 111.204 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.8 Cg_endo -69.68 -4.95 15.0 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.62 -28.66 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.159 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -67.9 -50.24 57.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.23 -33.84 76.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -69.46 -53.84 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 47.0 mt -60.18 -31.84 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.142 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -64.71 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.48 -40.56 37.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.59 -54.41 46.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.46 -49.16 83.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.087 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 85.5 t -58.07 -56.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 71.7 t -49.03 -60.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.66 -39.1 45.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -61.97 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.24 -31.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.66 -26.55 54.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -75.34 -44.59 44.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.7 mt -75.13 -47.64 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.155 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.82 -59.91 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -51.94 -39.02 58.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -30.06 66.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.68 -40.8 65.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -87.36 -2.51 58.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -53.27 -31.96 46.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.6 p -126.17 -36.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t -51.07 156.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.82 -33.03 4.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -162.53 133.3 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -127.07 -74.21 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.6 -170.68 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 179.861 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.18 112.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.139 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.05 125.34 50.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -30.23 0.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.4 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m 51.58 45.47 28.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 t -103.36 -13.87 16.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.92 82.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.2 92.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.54 -64.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.9 mt -71.46 -57.68 4.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.634 0.73 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.1 Cg_endo -69.83 -5.82 17.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.341 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.43 -27.89 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.11 -49.43 72.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.08 -32.22 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -51.58 14.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.825 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.4 mt -62.65 -37.82 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -55.63 19.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.59 -48.01 57.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -52.89 62.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -60.03 -30.9 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.072 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.55 -57.69 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.054 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.6 t -51.69 -57.63 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.76 -49.32 66.63 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.0 tp -51.91 -61.28 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.362 . . . . 0.0 110.899 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.4 t -51.43 -31.67 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -39.38 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.56 -35.94 82.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.4 mt -83.58 -39.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.88 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.41 -30.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -71.38 -58.88 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -61.28 -26.74 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -20.57 32.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -88.07 -7.73 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.87 14.59 9.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -46.88 88.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? 62.85 93.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.36 127.71 7.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -76.51 132.19 39.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 -63.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.07 112.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 125.13 50.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.59 -30.66 0.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m 51.64 45.33 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 6.8 t -103.45 -13.63 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.89 82.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.03 92.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.25 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.518 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 2.9 mt -71.5 -57.8 4.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.587 0.708 . . . . 0.0 111.154 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.6 Cg_endo -69.77 -5.91 17.35 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.748 2.298 . . . . 0.0 112.306 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 p -50.52 -27.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.06 -49.38 72.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.03 -32.51 74.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -51.34 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 36.4 mt -62.69 -37.93 80.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.19 -56.0 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.34 -48.1 55.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.05 -52.36 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 46.8 t -60.78 -31.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.07 -58.19 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 89.9 t -51.58 -57.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.187 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -48.73 67.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.549 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.4 tp -51.76 -61.5 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 47.9 t -51.52 -31.68 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.28 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -66.97 -34.61 78.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.84 -39.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.17 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.58 -61.12 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 61.66 14.82 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -71.44 -58.13 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.959 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -61.87 -26.62 68.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -21.3 31.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -90.97 -8.4 49.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.74 14.78 9.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -46.77 88.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? 63.11 94.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.55 128.07 7.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -75.93 131.81 39.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -62.92 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.861 0.362 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -168.98 177.39 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.17 158.65 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.14 33.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.445 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -51.63 -41.97 61.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.11 114.71 6.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.28 152.33 20.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.67 24.69 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.88 -59.17 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -68.39 -57.15 9.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 0.0 111.1 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.8 Cg_endo -69.78 -2.7 10.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.617 2.211 . . . . 0.0 112.368 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.88 -29.15 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.32 -49.31 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.23 -33.19 75.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.21 -50.77 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.11 -38.89 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.0 -56.98 13.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.34 -48.26 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.82 -53.1 43.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 t -54.36 -51.56 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.4 t -58.07 -47.84 85.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.8 t -53.82 -63.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.94 62.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -52.53 -60.48 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 110.905 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.48 -37.91 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -26.86 67.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.16 -47.21 20.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.72 -32.13 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.22 3.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' B' ' 133' ' ' TRP . 14.1 t80 -53.5 -28.15 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -68.98 -58.77 3.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.75 -23.67 53.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.456 ' CG ' ' CE1' ' B' ' 130' ' ' PHE . 20.5 m95 -81.98 -19.48 40.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.12 -9.2 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.88 8.45 6.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 90.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.0 -174.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.26 -177.88 6.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -162.41 31.88 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 61.02 175.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.884 0.373 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.2 177.39 4.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.03 158.58 1.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.14 33.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 3.6 t -51.66 -42.01 61.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.127 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.3 114.84 6.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.25 152.29 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.56 24.77 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.93 -59.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 0.8 OUTLIER -68.54 -57.17 8.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.59 0.709 . . . . 0.0 111.089 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.9 Cg_endo -69.73 -2.84 10.84 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.69 2.26 . . . . 0.0 112.379 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -48.75 -29.04 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.189 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.45 -49.43 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.29 -33.02 74.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -73.36 -50.64 20.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -65.37 -38.68 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -57.23 12.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.11 -48.49 61.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.11 41.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 t -54.43 -51.45 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.27 -47.71 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 96.8 t -53.96 -63.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.084 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.63 -51.05 61.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -52.36 -60.58 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.33 -38.13 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.64 67.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.051 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -77.23 -47.33 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.6 -31.97 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.92 -59.14 2.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 33' ' ' TRP . 13.3 t80 -53.05 -29.04 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -69.22 -60.42 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.948 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -59.36 -25.29 64.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.813 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . 0.525 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 20.3 m95 -86.45 -14.71 42.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -75.71 -28.86 58.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.93 -30.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.81 91.16 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.14 -175.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.92 -175.89 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -160.94 31.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 60.25 175.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.42 117.49 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.132 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -121.31 179.68 4.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.94 -66.39 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m 64.1 45.21 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.064 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 p -89.01 -46.78 8.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.41 112.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.85 25.45 14.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.843 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.3 -42.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 4.7 mt -69.42 -57.27 7.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.541 0.686 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.0 Cg_endo -69.72 -45.98 1.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.662 2.242 . . . . 0.0 112.414 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.29 -28.28 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.108 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -49.58 69.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -29.47 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -74.92 -50.52 16.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -66.47 -38.18 81.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.141 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.15 -56.08 10.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.4 -44.1 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.36 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -52.66 -35.16 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -72.4 -50.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.76 -58.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.56 -56.24 26.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.472 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.4 mt -50.92 -61.73 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.943 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.8 t -53.59 -32.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB3' ' CZ3' ' B' ' 133' ' ' TRP . . . -73.23 -32.77 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' B' ' 137' ' ' LYS . 60.4 t80 -73.61 -34.37 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.24 -54.27 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.12 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.53 ' CD1' ' HB3' ' B' ' 133' ' ' TRP . 22.0 t80 -44.73 -58.98 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -37.91 64.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.96 -26.02 64.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -21.1 29.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -45.29 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -67.23 -26.67 66.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.5 103.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.57 169.46 17.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 61.62 99.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -175.67 177.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -179.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.32 116.86 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 41.0 mtt-85 -121.88 179.99 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.53 -66.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.3 m 63.92 45.44 4.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 0.0 111.124 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.4 p -88.97 -46.74 8.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.24 112.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.91 25.45 13.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.939 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.29 -41.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 4.6 mt -69.47 -57.19 7.24 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.642 0.734 . . . . 0.0 111.108 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.1 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.735 2.29 . . . . 0.0 112.352 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.8 p -50.97 -28.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -49.42 74.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -31.73 72.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -73.06 -49.61 27.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 33.4 mt -62.24 -33.98 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -58.52 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.04 -43.04 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -57.71 11.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 46.4 t -53.59 -35.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 93.1 t -72.05 -51.39 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.175 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 94.2 t -51.35 -58.96 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.7 -56.28 25.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 40.7 mt -50.96 -61.99 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 76.0 t -52.67 -31.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.93 -30.97 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.09 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -79.03 -35.48 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.4 -63.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.48 -62.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 10.3 t80 73.64 -59.41 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -35.24 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -24.68 47.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . 0.552 ' CZ3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -84.64 -22.57 29.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . 0.476 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -86.62 -46.69 9.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.87 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 3.2 m -68.12 -26.11 65.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.9 103.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . 0.569 ' HA ' ' CE1' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -137.17 169.24 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 61.24 99.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -175.51 177.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -179.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.9 p -118.38 142.65 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -162.33 -177.63 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.56 156.31 4.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 158.99 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 0.0 111.121 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -172.93 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 63.34 104.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 62.99 22.62 13.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.18 -73.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.515 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.2 mp -72.46 -57.87 3.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.591 0.71 . . . . 0.0 111.109 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.2 Cg_endo -69.71 -5.68 16.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.381 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p -50.07 -28.3 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -68.75 -49.94 54.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.02 -32.23 73.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -73.24 -52.84 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 mt -65.5 -36.55 77.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 tt -65.27 -57.25 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.52 -49.13 56.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.03 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.4 t -54.51 -53.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.98 -51.86 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.49 -58.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.44 58.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.28 -54.5 43.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 0.0 110.976 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.17 -32.75 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.76 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -76.64 -45.2 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.85 -53.58 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.81 -61.22 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -52.43 -29.99 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -75.97 -36.96 59.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -63.91 -38.63 91.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.485 ' CD2' ' CZ ' ' B' ' 130' ' ' PHE . 1.5 m-90 -86.79 -16.03 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -58.5 -45.87 87.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.7 t -147.1 -40.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.64 156.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.73 75.38 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.04 -39.5 92.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.9 95.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 166.38 33.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 43.3 p -118.19 142.88 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -162.08 -177.83 6.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.64 156.02 4.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 159.27 2.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 111.162 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.84 -173.0 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.098 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.33 105.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 63.12 22.68 13.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.36 -73.4 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.513 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 1.2 mp -72.66 -57.76 3.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.596 0.712 . . . . 0.0 111.149 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.0 Cg_endo -69.91 -5.47 16.37 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.588 2.192 . . . . 0.0 112.345 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.98 -28.47 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.82 -50.29 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -69.95 -53.43 17.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 47.0 mt -60.98 -32.64 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -64.29 0.9 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.41 -45.94 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -54.22 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 57.6 t -54.9 -52.57 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.137 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.88 -44.08 85.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.5 -63.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.21 95.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.21 -61.83 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.13 -33.46 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.059 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.64 -25.15 60.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -77.06 -45.86 25.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 9.0 mt -74.77 -53.98 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.0 -61.16 2.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 33' ' ' TRP . 20.4 t80 -51.95 -30.05 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.16 -37.07 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -63.74 -38.44 91.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -87.31 -2.04 58.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -51.9 -32.89 34.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 22.1 t -125.27 -36.25 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.39 156.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.13 75.3 1.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.03 92.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.99 95.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.05 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.794 0.33 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.99 179.55 6.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -64.14 -26.65 68.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.81 10.14 21.63 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.496 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m 51.39 80.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.156 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.65 -72.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 54.26 24.3 4.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -168.87 27.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mp -149.19 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.518 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mt -70.23 -57.97 5.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.559 0.695 . . . . 0.0 111.129 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.3 Cg_endo -69.76 -35.97 11.66 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.304 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.76 -21.89 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.74 -49.78 28.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -27.48 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.8 m -77.14 -51.5 10.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.9 mt -67.18 -40.56 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.5 -55.25 18.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.45 -47.82 56.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.07 -56.54 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.5 t -53.15 -35.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.7 t -73.36 -45.91 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.426 HG13 ' CE2' ' B' ' 133' ' ' TRP . 57.8 t -55.1 -59.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.477 ' HA2' ' CE3' ' B' ' 133' ' ' TRP . . . -59.79 -51.45 58.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.1 tp -51.7 -61.94 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.377 . . . . 0.0 110.976 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.2 t -54.25 -34.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.04 -29.72 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -75.82 -35.06 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.06 -45.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.92 -61.18 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -44.76 -54.84 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.1 -44.19 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -59.78 -26.26 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -86.53 -17.56 33.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.95 -37.61 84.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.9 -34.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.43 103.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 175.52 9.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.02 86.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -158.63 82.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.67 164.43 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.81 178.66 7.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.145 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.19 -27.14 68.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 10.66 21.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.545 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 3.3 m 53.41 79.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.0 -74.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.24 21.8 3.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 178.62 30.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 6.5 mp -141.66 -58.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.521 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 3.0 mt -73.04 -58.2 2.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.695 0.759 . . . . 0.0 111.159 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.3 Cg_endo -69.74 -38.25 8.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.639 2.226 . . . . 0.0 112.324 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -52.69 -26.69 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.45 -49.46 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -30.73 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 52.8 m -73.66 -50.52 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 41.1 mt -61.62 -35.93 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -56.88 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.19 -47.26 54.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.74 -56.5 18.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 46.0 t -52.53 -35.67 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 93.8 t -73.53 -44.92 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' A' ' 22' ' ' VAL . 61.0 t -55.36 -59.88 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.11 -50.17 70.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 57.2 tp -53.19 -62.41 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 65.9 t -54.77 -36.1 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.65 62.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.71 -33.54 40.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.76 -63.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.11 -64.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 3.0 t80 71.77 -62.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -42.53 87.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -56.96 -24.09 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . 0.477 ' CE3' ' HA2' ' A' ' 23' ' ' GLY . 2.8 m95 -99.14 -9.69 23.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.37 -34.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.5 103.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.86 174.57 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.83 86.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -158.54 83.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.54 164.27 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.951 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.21 137.78 44.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -154.15 127.71 8.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.1 35.01 1.95 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.7 p -59.6 -171.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.42 104.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -94.0 141.27 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.33 16.22 9.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 mp -121.91 -73.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.2 mt -70.56 -57.66 5.28 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.8 Cg_endo -69.79 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 p -49.37 -28.94 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -60.32 -46.86 88.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.74 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -46.08 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.791 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.3 mt -63.27 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.2 tp -53.76 -60.2 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.04 -50.05 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.64 63.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.8 t -58.04 -51.52 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.164 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 HG13 HG21 ' B' ' 122' ' ' VAL . 48.7 t -57.81 -48.34 83.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -53.68 -63.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.44 -51.78 56.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.544 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -52.0 -60.59 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.955 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.2 t -58.22 -38.05 66.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.99 67.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -77.02 -47.31 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.5 -32.22 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.03 -61.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -54.62 -30.25 54.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -80.29 -51.73 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -36.79 51.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.612 ' HB3' ' CE1' ' B' ' 130' ' ' PHE . 5.9 m0 -86.07 -20.92 28.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.26 -45.26 49.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -69.97 -26.42 64.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 -40.01 61.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.803 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.59 -178.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 55.26 57.85 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.09 170.65 16.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 140.11 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.832 0.349 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.11 138.09 45.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.132 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -154.16 127.26 8.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.05 34.44 1.93 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.477 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 29.2 p -59.63 -171.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.71 104.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.1 135.1 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.18 14.87 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 9.4 mp -118.13 -56.51 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 5.2 mt -70.32 -57.61 5.65 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.181 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.2 Cg_endo -69.82 -5.17 15.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 3.0 p -49.46 -29.26 3.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.44 -49.6 75.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.967 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' CYS . . . . . 0.486 ' HA ' ' CD2' ' B' ' 117' ' ' LEU . 0.1 OUTLIER -68.72 -42.04 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.857 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -37.52 85.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 45.0 mt -75.24 -55.29 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' B' ' 114' ' ' CYS . 3.5 pp -58.48 -39.34 79.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.92 -50.57 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.47 68.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 41.7 t -63.14 -51.33 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 93.6 t -57.71 -48.73 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.481 HG21 HG13 ' A' ' 21' ' ' VAL . 97.3 t -53.55 -63.49 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.37 -51.77 56.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -51.83 -60.74 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.12 -38.04 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.118 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.38 -26.92 67.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -76.99 -47.29 21.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.79 -31.96 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.31 -60.63 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.612 ' CE1' ' HB3' ' A' ' 33' ' ' TRP . 12.4 t80 -52.39 -30.61 29.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -80.06 -50.77 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.44 -36.58 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -85.57 -21.22 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.41 -45.3 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -70.1 -26.59 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -39.41 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.84 -178.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 55.24 57.39 5.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.46 170.76 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.95 140.04 32.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.907 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 CA-C-O 120.804 0.251 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.531 HG22 HD12 ' A' ' 16' ' ' ILE . 7.7 p -79.53 -36.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -49.29 47.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.43 -28.3 69.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 m -77.13 -52.27 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 20' ' ' VAL . 75.0 mt -65.13 -37.96 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -66.92 -57.26 7.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.57 -38.62 55.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.41 20.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -57.93 -40.71 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 17' ' ' LEU . 61.7 t -61.86 -58.5 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.6 t -52.06 -60.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.33 -48.18 54.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 28' ' ' ILE . 54.9 tp -51.7 -61.8 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' VAL . 44.5 t -52.37 -32.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.56 69.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -66.41 -34.97 79.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.3 -39.68 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.99 64.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.98 -26.38 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.57 -45.98 15.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.799 0.249 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.541 HG22 HD12 ' B' ' 116' ' ' ILE . 7.6 p -79.51 -36.18 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.174 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.43 -49.48 41.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.57 -28.25 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.4 m -77.02 -51.97 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.645 ' O ' HG23 ' B' ' 120' ' ' VAL . 75.8 mt -65.5 -38.12 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.671 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -66.71 -57.67 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.51 -38.79 55.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.64 18.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.4 t -57.44 -40.13 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 117' ' ' LEU . 57.4 t -62.55 -58.52 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -51.75 -61.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.18 -48.52 52.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.896 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.27 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.696 HG22 HD11 ' A' ' 16' ' ' ILE . 2.9 p -51.31 -27.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.93 -49.41 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.72 -31.14 71.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -49.19 22.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.955 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 20' ' ' VAL . 43.0 mt -65.79 -38.62 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.81 8.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.23 -45.13 61.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -54.52 39.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 16' ' ' ILE . 26.3 t -55.07 -48.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.44 -53.24 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' ALA . 98.9 t -50.69 -61.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.83 49.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -55.49 -55.56 30.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 122' ' ' VAL . 62.0 t -58.65 -33.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -27.51 60.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -74.01 -45.38 50.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.429 HD11 HD23 ' A' ' 24' ' ' LEU . 4.4 mt -74.42 -47.42 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -59.84 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -51.92 -30.39 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.29 -42.85 35.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.965 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.719 HG22 HD11 ' B' ' 116' ' ' ILE . 2.9 p -51.39 -27.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.85 -49.44 70.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 t -65.8 -31.59 72.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -49.07 25.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.731 ' O ' HG23 ' B' ' 120' ' ' VAL . 42.3 mt -65.73 -38.22 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -57.72 9.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.657 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.24 -45.86 62.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.116 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.27 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 116' ' ' ILE . 26.0 t -54.97 -50.05 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.07 -52.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.657 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -51.64 -63.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.05 89.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.864 0.277 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.656 HG22 ' CD1' ' A' ' 16' ' ' ILE . 2.8 p -50.26 -28.12 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.39 -49.39 71.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -64.09 -32.45 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.9 m -74.59 -50.83 16.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.6 mt -65.55 -37.84 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -63.76 -56.7 13.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.41 -47.56 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.23 -53.25 53.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.139 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 38.4 t -57.74 -51.65 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' LEU . 62.1 t -55.61 -55.26 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.1 t -50.56 -60.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.84 -39.78 48.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.55 -57.17 13.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.9 t -57.9 -32.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.98 -27.01 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -74.54 -45.73 43.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.436 HD11 HD23 ' A' ' 24' ' ' LEU . 4.2 mt -73.13 -46.31 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -61.18 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -52.17 -52.21 53.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -53.71 -37.28 63.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.819 0.258 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' B' ' 116' ' ' ILE . 2.8 p -50.24 -28.27 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.26 -49.36 72.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.03 -32.47 74.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.0 m -74.53 -50.94 16.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.726 ' O ' HG23 ' B' ' 120' ' ' VAL . 55.8 mt -65.32 -37.43 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.413 ' O ' HG23 ' B' ' 121' ' ' VAL . 1.0 OUTLIER -64.03 -56.41 15.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.647 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.47 -47.46 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.57 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 116' ' ' ILE . 34.6 t -56.52 -50.91 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 117' ' ' LEU . 61.4 t -56.66 -53.45 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 118' ' ' ALA . 99.0 t -51.06 -63.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.55 -42.93 85.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.82 0.258 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.3 p -49.66 -28.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -68.87 -49.93 54.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -63.43 -32.33 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 m -73.56 -53.6 10.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.707 ' O ' HG23 ' A' ' 20' ' ' VAL . 44.2 mt -64.34 -36.94 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.154 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 5.7 tt -66.42 -56.46 10.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.504 ' N ' HD23 ' A' ' 17' ' ' LEU . . . -49.88 -45.6 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -55.22 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 16' ' ' ILE . 54.6 t -55.92 -44.68 78.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.5 t -56.7 -59.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' B' ' 121' ' ' VAL . 65.8 t -51.34 -63.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.67 -41.88 51.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.572 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -61.61 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.85 -30.01 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.53 50.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -74.86 -43.79 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.4 -46.56 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.07 -59.53 5.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -51.65 -40.1 59.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -29.16 64.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.808 0.253 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.565 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.62 -28.66 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.159 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -67.9 -50.24 57.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.23 -33.84 76.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -69.46 -53.84 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.734 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.18 -31.84 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.142 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -64.71 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.563 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -49.48 -40.56 37.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.59 -54.41 46.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 116' ' ' ILE . 40.7 t -58.46 -49.16 83.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.087 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 22' ' ' VAL . 85.5 t -58.07 -56.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 118' ' ' ALA . 71.7 t -49.03 -60.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.66 -39.1 45.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.86 0.275 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -50.43 -27.89 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.11 -49.43 72.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.08 -32.22 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -51.58 14.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.825 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 12' ' ' VAL . 36.4 mt -62.65 -37.82 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -64.44 -55.63 19.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.59 -48.01 57.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -52.89 62.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 16' ' ' ILE . 46.6 t -60.03 -30.9 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 17' ' ' LEU . 88.9 t -71.55 -57.69 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.054 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.643 HG22 HG22 ' B' ' 122' ' ' VAL . 82.6 t -51.69 -57.63 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.76 -49.32 66.63 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 28' ' ' ILE . 40.0 tp -51.91 -61.28 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.362 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 21' ' ' VAL . 47.4 t -51.43 -31.67 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -39.38 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.56 -35.94 82.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 24' ' ' LEU . 3.4 mt -83.58 -39.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.88 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.41 -30.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -71.38 -58.88 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.807 0.253 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 2.8 p -50.52 -27.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.046 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.06 -49.38 72.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.03 -32.51 74.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -51.34 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.712 HD11 HG22 ' B' ' 112' ' ' VAL . 36.4 mt -62.69 -37.93 80.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.162 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.691 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -64.19 -56.0 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.34 -48.1 55.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.05 -52.36 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.8 t -60.78 -31.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 117' ' ' LEU . 90.1 t -71.07 -58.19 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 22' ' ' VAL . 89.9 t -51.58 -57.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -48.73 67.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.549 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.792 0.247 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.5 p -48.88 -29.15 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.32 -49.31 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.23 -33.19 75.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.21 -50.77 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.4 mt -65.11 -38.89 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.159 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.0 -56.98 13.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.34 -48.26 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.82 -53.1 43.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -54.36 -51.56 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.4 t -58.07 -47.84 85.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' ALA . 97.8 t -53.82 -63.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.94 62.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 25' ' ' VAL . 1.3 tm? -52.53 -60.48 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 24' ' ' LEU . 98.3 t -58.48 -37.91 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -26.86 67.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.16 -47.21 20.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.72 -32.13 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.22 3.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.5 -28.15 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -68.98 -58.77 3.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 CA-C-O 120.822 0.259 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -48.75 -29.04 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.189 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.45 -49.43 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.29 -33.02 74.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -73.36 -50.64 20.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.748 ' O ' HG23 ' B' ' 120' ' ' VAL . 53.6 mt -65.37 -38.68 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -57.23 12.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.693 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.11 -48.49 61.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.11 41.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.748 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.2 t -54.43 -51.45 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.201 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.27 -47.71 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.693 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -53.96 -63.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.084 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.63 -51.05 61.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.448 ' O ' HD22 ' B' ' 124' ' ' LEU . 1.4 tm? . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.173 0 CA-C-O 120.885 0.285 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 16' ' ' ILE . 4.6 p -51.29 -28.28 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -49.58 69.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -29.47 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -74.92 -50.52 16.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 12' ' ' VAL . 49.6 mt -66.47 -38.18 81.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.141 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -68.15 -56.08 10.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.4 -44.1 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.36 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.695 HG12 HD12 ' A' ' 24' ' ' LEU . 46.6 t -52.66 -35.16 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.2 t -72.4 -50.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.842 HG22 HG22 ' B' ' 122' ' ' VAL . 87.2 t -51.76 -58.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.56 -56.24 26.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.472 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.733 ' O ' HD12 ' A' ' 28' ' ' ILE . 41.4 mt -50.92 -61.73 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.943 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 21' ' ' VAL . 67.8 t -53.59 -32.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.23 -32.77 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -73.61 -34.37 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.733 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.24 -54.27 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.12 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -44.73 -58.98 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -37.91 64.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.854 0.272 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 4.8 p -50.97 -28.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -49.42 74.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -31.73 72.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -73.06 -49.61 27.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.715 ' O ' HG23 ' B' ' 120' ' ' VAL . 33.4 mt -62.24 -33.98 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.527 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -67.03 -58.52 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.694 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.04 -43.04 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -57.71 11.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.4 t -53.59 -35.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.1 t -72.05 -51.39 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.175 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.842 HG22 HG22 ' A' ' 22' ' ' VAL . 94.2 t -51.35 -58.96 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.7 -56.28 25.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.696 HD12 HG12 ' B' ' 120' ' ' VAL . 40.7 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.222 0 CA-C-O 120.808 0.253 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.4 p -50.07 -28.3 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -68.75 -49.94 54.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.02 -32.23 73.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -73.24 -52.84 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 20' ' ' VAL . 45.7 mt -65.5 -36.55 77.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 18' ' ' ALA . 5.5 tt -65.27 -57.25 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.52 -49.13 56.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.03 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 16' ' ' ILE . 63.4 t -54.51 -53.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.98 -51.86 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 18' ' ' ALA . 69.2 t -49.49 -58.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.44 58.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.456 ' HA ' HD13 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -61.28 -54.5 43.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 0.0 110.976 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.17 -32.75 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.76 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -76.64 -45.2 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.85 -53.58 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.81 -61.22 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -52.43 -29.99 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -75.97 -36.96 59.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.85 0.271 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.548 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.98 -28.47 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.82 -50.29 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -69.95 -53.43 17.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.729 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.98 -32.64 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -64.29 0.9 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.669 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -48.41 -45.94 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -54.22 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 116' ' ' ILE . 57.6 t -54.9 -52.57 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 22' ' ' VAL . 59.9 t -57.88 -44.08 85.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.669 HG23 ' O ' ' B' ' 118' ' ' ALA . 53.8 t -56.5 -63.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.21 95.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.452 HD13 ' C ' ' B' ' 124' ' ' LEU . 1.9 tm? . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.848 0.27 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -55.76 -21.89 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.74 -49.78 28.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -27.48 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.8 m -77.14 -51.5 10.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.691 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.9 mt -67.18 -40.56 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.5 -55.25 18.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.45 -47.82 56.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.07 -56.54 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 16' ' ' ILE . 43.5 t -53.15 -35.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 17' ' ' LEU . 99.7 t -73.36 -45.91 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.958 HG22 HG22 ' B' ' 122' ' ' VAL . 57.8 t -55.1 -59.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.45 58.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 28' ' ' ILE . 55.1 tp -51.7 -61.94 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.377 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' VAL . 70.2 t -54.25 -34.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.04 -29.72 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -75.82 -35.06 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.707 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -81.06 -45.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.92 -61.18 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -44.76 -54.84 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.1 -44.19 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.768 0.237 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.677 HG22 HD11 ' B' ' 116' ' ' ILE . 4.4 p -52.69 -26.69 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.45 -49.46 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -30.73 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 52.8 m -73.66 -50.52 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.725 ' O ' HG23 ' B' ' 120' ' ' VAL . 41.1 mt -61.62 -35.93 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.435 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -65.76 -56.88 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.756 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.19 -47.26 54.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.74 -56.5 18.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.0 t -52.53 -35.67 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.8 t -73.53 -44.92 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 22' ' ' VAL . 61.0 t -55.36 -59.88 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.11 -50.17 70.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.917 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.849 0.27 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 16' ' ' ILE . 3.4 p -49.37 -28.94 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -60.32 -46.86 88.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.74 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -46.08 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.791 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.3 mt -63.27 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 8.2 tp -53.76 -60.2 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.04 -50.05 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.64 63.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 16' ' ' ILE . 47.8 t -58.04 -51.52 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.7 t -57.81 -48.34 83.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 18' ' ' ALA . 85.1 t -53.68 -63.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.44 -51.78 56.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.544 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 28' ' ' ILE . 1.3 tm? -52.0 -60.59 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 24' ' ' LEU . 94.2 t -58.22 -38.05 66.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.99 67.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -77.02 -47.31 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.5 -32.22 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.03 -61.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -54.62 -30.25 54.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -80.29 -51.73 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.841 0.267 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.687 HG22 HD11 ' B' ' 116' ' ' ILE . 3.0 p -49.46 -29.26 3.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.44 -49.6 75.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.967 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' CYS . . . . . 0.495 ' HA ' ' CD2' ' B' ' 117' ' ' LEU . 0.1 OUTLIER -68.72 -42.04 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.857 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -37.52 85.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.687 HD11 HG22 ' B' ' 112' ' ' VAL . 45.0 mt -75.24 -55.29 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 121' ' ' VAL . 3.5 pp -58.48 -39.34 79.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ALA . . . . . 0.644 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -64.92 -50.57 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.47 68.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 116' ' ' ILE . 41.7 t -63.14 -51.33 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.6 t -57.71 -48.73 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.644 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -53.55 -63.49 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.37 -51.77 56.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.463 ' O ' HD22 ' B' ' 124' ' ' LEU . 1.3 tm? . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.2 p -82.77 -35.39 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 52.93 51.66 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.92 5.84 83.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.12 34.83 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.143 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.731 ' HB ' HD12 ' A' ' 10' ' ' ILE . 6.2 t -88.31 -25.13 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.3 74.24 0.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.77 89.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -176.91 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.731 HD12 ' HB ' ' A' ' 6' ' ' THR . 3.9 mt -47.12 -58.62 6.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.676 ' CD ' HG21 ' A' ' 6' ' ' THR . 54.3 Cg_endo -69.69 52.54 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.7 2.266 . . . . 0.0 112.387 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.531 HG22 HD12 ' A' ' 16' ' ' ILE . 7.7 p -79.53 -36.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -49.29 47.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.43 -28.3 69.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 m -77.13 -52.27 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 20' ' ' VAL . 75.0 mt -65.13 -37.96 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -66.92 -57.26 7.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.57 -38.62 55.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.41 20.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -57.93 -40.71 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 17' ' ' LEU . 61.7 t -61.86 -58.5 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.6 t -52.06 -60.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.33 -48.18 54.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 28' ' ' ILE . 54.9 tp -51.7 -61.8 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' VAL . 44.5 t -52.37 -32.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.56 69.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -66.41 -34.97 79.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.3 -39.68 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.99 64.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.98 -26.38 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.57 -45.98 15.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -64.32 -30.9 71.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -86.25 -17.28 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -55.22 -25.87 35.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.57 -34.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.66 146.6 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.39 175.18 7.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.9 -60.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 55.99 65.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? 61.01 97.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.869 0.366 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 81.2 p -83.06 -36.13 25.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 52.18 51.39 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.16 7.74 79.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.56 29.96 6.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 2.2 t -94.71 -19.38 20.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.18 83.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.46 93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -62.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 3.6 mt -50.33 -58.71 8.9 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 111.132 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.4 Cg_endo -69.81 53.09 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.319 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.541 HG22 HD12 ' B' ' 116' ' ' ILE . 7.6 p -79.51 -36.18 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.174 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.43 -49.48 41.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.57 -28.25 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.4 m -77.02 -51.97 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.645 ' O ' HG23 ' B' ' 120' ' ' VAL . 75.8 mt -65.5 -38.12 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.671 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -66.71 -57.67 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.51 -38.79 55.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.64 18.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.4 t -57.44 -40.13 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 117' ' ' LEU . 57.4 t -62.55 -58.52 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -51.75 -61.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.18 -48.52 52.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.732 ' O ' HD12 ' B' ' 128' ' ' ILE . 54.8 tp -51.7 -61.85 1.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 121' ' ' VAL . 44.7 t -52.44 -32.88 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.107 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.37 -35.07 79.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.732 HD12 ' O ' ' B' ' 124' ' ' LEU . 2.9 mp -84.21 -39.74 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.95 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.87 -26.34 66.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.95 -45.81 14.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -63.94 -29.92 71.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -86.87 -16.46 35.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.02 -25.5 44.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.48 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.83 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.92 146.86 7.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 174.79 7.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -96.09 -60.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 56.25 65.51 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? 61.19 97.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.87 0.367 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.623 ' OG1' HG21 ' B' ' 102' ' ' THR . 0.2 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.156 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.68 -74.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.02 27.84 23.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -29.71 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.643 HG22 ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -71.84 131.66 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -122.22 -65.47 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -95.66 24.41 5.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 6' ' ' THR . 10.7 mp -117.01 -33.76 4.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 mt -70.01 -57.19 6.47 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.539 0.685 . . . . 0.0 111.156 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.2 Cg_endo -69.75 -45.29 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.696 HG22 HD11 ' A' ' 16' ' ' ILE . 2.9 p -51.31 -27.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.93 -49.41 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.72 -31.14 71.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -49.19 22.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.955 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 20' ' ' VAL . 43.0 mt -65.79 -38.62 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.81 8.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.23 -45.13 61.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -54.52 39.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 16' ' ' ILE . 26.3 t -55.07 -48.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.44 -53.24 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' ALA . 98.9 t -50.69 -61.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.83 49.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -55.49 -55.56 30.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 122' ' ' VAL . 62.0 t -58.65 -33.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -27.51 60.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -74.01 -45.38 50.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.429 HD11 HD23 ' A' ' 24' ' ' LEU . 4.4 mt -74.42 -47.42 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -59.84 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -51.92 -30.39 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.29 -42.85 35.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -59.91 -26.24 65.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.413 ' CE2' ' CE1' ' B' ' 130' ' ' PHE . 75.4 m95 -79.35 -21.31 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -40.52 70.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 m -94.26 9.27 38.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -93.03 43.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.56 -170.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -132.73 111.04 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -106.34 101.52 10.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.56 103.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 41.1 mtt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.892 0.377 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.623 HG21 ' OG1' ' A' ' 2' ' ' THR . 0.2 OUTLIER -136.91 -172.66 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.173 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -74.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.01 27.91 23.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -29.71 19.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.657 HG22 ' HB2' ' B' ' 109' ' ' LEU . 0.1 OUTLIER -71.69 131.68 43.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -122.27 -65.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.447 ' C ' HD12 ' B' ' 109' ' ' LEU . 0.8 OUTLIER -95.82 24.48 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.657 ' HB2' HG22 ' B' ' 106' ' ' THR . 10.6 mp -117.03 -33.6 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 2.5 mt -70.08 -57.34 6.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.2 Cg_endo -69.81 -45.0 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.297 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.719 HG22 HD11 ' B' ' 116' ' ' ILE . 2.9 p -51.39 -27.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.85 -49.44 70.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 t -65.8 -31.59 72.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -49.07 25.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.731 ' O ' HG23 ' B' ' 120' ' ' VAL . 42.3 mt -65.73 -38.22 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -57.72 9.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.657 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.24 -45.86 62.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.116 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.27 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 116' ' ' ILE . 26.0 t -54.97 -50.05 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 125' ' ' VAL . 99.0 t -58.07 -52.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.657 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -51.64 -63.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.05 89.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -56.39 18.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.987 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 121' ' ' VAL . 47.1 t -57.83 -32.44 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.47 60.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -73.52 -45.08 55.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.38 -47.35 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.12 -59.88 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.413 ' CE1' ' CE2' ' A' ' 33' ' ' TRP . 18.0 t80 -51.89 -30.22 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -42.74 39.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -59.45 -26.35 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -79.19 -21.27 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -40.52 70.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 3.0 m -94.03 9.52 37.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -92.98 43.93 1.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.84 -170.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -132.66 111.22 11.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -106.35 101.77 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 103.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.855 0.36 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.99 110.66 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.143 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -144.24 40.04 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.75 -20.28 63.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.16 41.83 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.156 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.72 -46.78 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 50.13 27.97 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.56 32.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.58 -74.92 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mt -71.58 -57.75 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.647 0.737 . . . . 0.0 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.6 Cg_endo -69.77 -5.71 16.87 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.746 2.297 . . . . 0.0 112.335 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.656 HG22 ' CD1' ' A' ' 16' ' ' ILE . 2.8 p -50.26 -28.12 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.39 -49.39 71.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -64.09 -32.45 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.9 m -74.59 -50.83 16.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.6 mt -65.55 -37.84 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -63.76 -56.7 13.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.41 -47.56 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.23 -53.25 53.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.139 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 38.4 t -57.74 -51.65 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' LEU . 62.1 t -55.61 -55.26 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.1 t -50.56 -60.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.84 -39.78 48.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.55 -57.17 13.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.9 t -57.9 -32.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.98 -27.01 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -74.54 -45.73 43.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.436 HD11 HD23 ' A' ' 24' ' ' LEU . 4.2 mt -73.13 -46.31 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -61.18 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -52.17 -52.21 53.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -53.71 -37.28 63.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -57.39 -26.03 60.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -17.46 34.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.66 -45.6 78.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 p -86.69 -37.66 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -51.7 -30.5 22.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 94.85 3.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.63 70.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -169.27 86.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.31 84.85 2.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.871 0.367 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.01 110.84 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -144.08 40.02 1.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.72 -20.53 63.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.487 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.17 41.6 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 111.18 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.91 -46.96 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 50.21 27.87 2.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.31 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.57 -74.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 2.1 mt -71.62 -57.79 4.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.711 0.767 . . . . 0.0 111.204 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.2 Cg_endo -69.78 -5.69 16.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.645 2.23 . . . . 0.0 112.39 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' B' ' 116' ' ' ILE . 2.8 p -50.24 -28.27 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.26 -49.36 72.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.03 -32.47 74.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.0 m -74.53 -50.94 16.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.726 ' O ' HG23 ' B' ' 120' ' ' VAL . 55.8 mt -65.32 -37.43 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.413 ' O ' HG23 ' B' ' 121' ' ' VAL . 1.0 OUTLIER -64.03 -56.41 15.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.647 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.47 -47.46 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.57 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 116' ' ' ILE . 34.6 t -56.52 -50.91 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.414 ' O ' HG23 ' B' ' 125' ' ' VAL . 61.4 t -56.66 -53.45 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 118' ' ' ALA . 99.0 t -51.06 -63.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.55 -42.93 85.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -58.29 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 121' ' ' VAL . 59.6 t -57.43 -31.62 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.0 -27.38 57.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -74.53 -46.15 41.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mt -73.28 -46.06 51.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.118 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.69 -61.03 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -52.1 -52.48 51.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -54.22 -37.58 64.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -57.51 -25.62 60.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.825 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.36 -12.55 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -69.74 -70.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 1.8 p -106.17 -45.09 4.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.68 -30.36 21.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 94.8 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.23 70.79 0.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -169.11 86.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 84.85 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.11 138.73 12.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -72.41 138.17 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.62 -20.02 9.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 63.62 25.27 14.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.343 . . . . 0.0 111.155 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 136.93 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.201 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.612 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -107.26 88.5 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.16 22.93 13.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 7' ' ' ASP . 6.8 mp -89.14 -39.23 13.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.3 mt -71.36 -57.74 4.32 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 0.0 111.181 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.3 Cg_endo -69.8 -4.93 15.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.3 p -49.66 -28.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -68.87 -49.93 54.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -63.43 -32.33 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 m -73.56 -53.6 10.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.707 ' O ' HG23 ' A' ' 20' ' ' VAL . 44.2 mt -64.34 -36.94 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.154 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 5.7 tt -66.42 -56.46 10.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.504 ' N ' HD23 ' A' ' 17' ' ' LEU . . . -49.88 -45.6 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -55.22 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 16' ' ' ILE . 54.6 t -55.92 -44.68 78.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.5 t -56.7 -59.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' B' ' 121' ' ' VAL . 65.8 t -51.34 -63.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.67 -41.88 51.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.572 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -61.61 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.85 -30.01 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.53 50.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -74.86 -43.79 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.4 -46.56 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.07 -59.53 5.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -51.65 -40.1 59.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -29.16 64.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -73.51 -41.36 63.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -86.19 -16.45 37.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -56.97 -45.54 82.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.0 p -152.3 -40.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -50.01 158.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.72 -32.04 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -162.2 131.72 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -127.56 -74.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.82 -169.71 3.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.838 0.351 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.29 138.72 12.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -72.28 138.08 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.77 -20.48 8.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.46 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.8 m 63.32 25.73 14.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 0.0 111.213 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 137.56 44.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.617 ' H ' HD13 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -107.41 88.64 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.14 22.96 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.617 HD13 ' H ' ' B' ' 107' ' ' ASP . 6.8 mp -89.1 -39.08 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 5.3 mt -71.48 -57.63 4.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.672 0.749 . . . . 0.0 111.204 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.8 Cg_endo -69.68 -4.95 15.0 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.565 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.62 -28.66 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.159 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -67.9 -50.24 57.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.23 -33.84 76.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -69.46 -53.84 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.734 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.18 -31.84 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.142 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -64.71 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.563 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -49.48 -40.56 37.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.59 -54.41 46.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 116' ' ' ILE . 40.7 t -58.46 -49.16 83.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.087 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 22' ' ' VAL . 85.5 t -58.07 -56.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 118' ' ' ALA . 71.7 t -49.03 -60.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.66 -39.1 45.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -61.97 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.24 -31.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.66 -26.55 54.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -75.34 -44.59 44.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.7 mt -75.13 -47.64 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.155 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.419 ' HB1' ' CZ3' ' B' ' 133' ' ' TRP . . . -57.82 -59.91 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -51.94 -39.02 58.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -30.06 66.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.68 -40.8 65.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' TRP . . . . . 0.419 ' CZ3' ' HB1' ' B' ' 129' ' ' ALA . 10.2 m0 -87.36 -2.51 58.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -53.27 -31.96 46.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.6 p -126.17 -36.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t -51.07 156.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.82 -33.03 4.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -162.53 133.3 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -127.07 -74.21 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.6 -170.68 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 179.861 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.18 112.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.139 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.05 125.34 50.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -30.23 0.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.4 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m 51.58 45.47 28.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 10' ' ' ILE . 6.9 t -103.36 -13.87 16.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.92 82.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.2 92.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.54 -64.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.59 ' H ' HG21 ' A' ' 6' ' ' THR . 2.9 mt -71.46 -57.68 4.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.634 0.73 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.1 Cg_endo -69.83 -5.82 17.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.341 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -50.43 -27.89 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.11 -49.43 72.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.08 -32.22 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -51.58 14.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.825 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 12' ' ' VAL . 36.4 mt -62.65 -37.82 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -64.44 -55.63 19.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.59 -48.01 57.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -52.89 62.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 16' ' ' ILE . 46.6 t -60.03 -30.9 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 17' ' ' LEU . 88.9 t -71.55 -57.69 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.054 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.643 HG22 HG22 ' B' ' 122' ' ' VAL . 82.6 t -51.69 -57.63 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.76 -49.32 66.63 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 28' ' ' ILE . 40.0 tp -51.91 -61.28 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.362 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 21' ' ' VAL . 47.4 t -51.43 -31.67 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -39.38 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.56 -35.94 82.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 24' ' ' LEU . 3.4 mt -83.58 -39.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.88 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.41 -30.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -71.38 -58.88 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -61.28 -26.74 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -20.57 32.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -88.07 -7.73 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.87 14.59 9.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -46.88 88.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? 62.85 93.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.36 127.71 7.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -76.51 132.19 39.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 -63.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.07 112.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 125.13 50.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.59 -30.66 0.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m 51.64 45.33 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.589 HG21 ' H ' ' B' ' 110' ' ' ILE . 6.8 t -103.45 -13.63 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.89 82.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.03 92.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.25 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.589 ' H ' HG21 ' B' ' 106' ' ' THR . 2.9 mt -71.5 -57.8 4.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.587 0.708 . . . . 0.0 111.154 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.6 Cg_endo -69.77 -5.91 17.35 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.748 2.298 . . . . 0.0 112.306 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 2.8 p -50.52 -27.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.046 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.06 -49.38 72.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.03 -32.51 74.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -51.34 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.712 HD11 HG22 ' B' ' 112' ' ' VAL . 36.4 mt -62.69 -37.93 80.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.162 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.691 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -64.19 -56.0 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.34 -48.1 55.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.05 -52.36 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.8 t -60.78 -31.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 117' ' ' LEU . 90.1 t -71.07 -58.19 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 22' ' ' VAL . 89.9 t -51.58 -57.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -48.73 67.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.549 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.523 ' O ' HD12 ' B' ' 128' ' ' ILE . 44.4 tp -51.76 -61.5 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 121' ' ' VAL . 47.9 t -51.52 -31.68 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.28 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -66.97 -34.61 78.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.523 HD12 ' O ' ' B' ' 124' ' ' LEU . 3.4 mt -84.84 -39.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.17 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.58 -61.12 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 61.66 14.82 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -71.44 -58.13 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.959 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -61.87 -26.62 68.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -21.3 31.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -90.97 -8.4 49.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.74 14.78 9.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -46.77 88.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? 63.11 94.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.55 128.07 7.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -75.93 131.81 39.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -62.92 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' HG23 ' A' ' 2' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.861 0.362 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -168.98 177.39 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.17 158.65 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.14 33.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.445 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -51.63 -41.97 61.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.578 HG22 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -67.11 114.71 6.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.28 152.33 20.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.67 24.69 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -99.88 -59.17 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -68.39 -57.15 9.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 0.0 111.1 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.8 Cg_endo -69.78 -2.7 10.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.617 2.211 . . . . 0.0 112.368 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.5 p -48.88 -29.15 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.32 -49.31 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.23 -33.19 75.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.21 -50.77 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.4 mt -65.11 -38.89 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.159 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.0 -56.98 13.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.34 -48.26 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.82 -53.1 43.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -54.36 -51.56 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.4 t -58.07 -47.84 85.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' ALA . 97.8 t -53.82 -63.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.94 62.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 25' ' ' VAL . 1.3 tm? -52.53 -60.48 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 24' ' ' LEU . 98.3 t -58.48 -37.91 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -26.86 67.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.16 -47.21 20.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.72 -32.13 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.22 3.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' B' ' 133' ' ' TRP . 14.1 t80 -53.5 -28.15 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -68.98 -58.77 3.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.75 -23.67 53.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.456 ' CG ' ' CE1' ' B' ' 130' ' ' PHE . 20.5 m95 -81.98 -19.48 40.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.12 -9.2 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.88 8.45 6.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 90.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.0 -174.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.26 -177.88 6.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -162.41 31.88 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 61.02 175.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.54 ' O ' HG23 ' B' ' 102' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.884 0.373 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.54 HG23 ' O ' ' B' ' 101' ' ' MET . 0.2 OUTLIER -169.2 177.39 4.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.03 158.58 1.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.14 33.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 3.6 t -51.66 -42.01 61.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.127 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.575 HG22 HD23 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -67.3 114.84 6.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.25 152.29 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.56 24.77 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.575 HD23 HG22 ' B' ' 106' ' ' THR . 0.2 OUTLIER -99.93 -59.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 0.8 OUTLIER -68.54 -57.17 8.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.59 0.709 . . . . 0.0 111.089 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.9 Cg_endo -69.73 -2.84 10.84 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.69 2.26 . . . . 0.0 112.379 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -48.75 -29.04 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.189 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.45 -49.43 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.29 -33.02 74.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -73.36 -50.64 20.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.748 ' O ' HG23 ' B' ' 120' ' ' VAL . 53.6 mt -65.37 -38.68 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -57.23 12.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.693 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.11 -48.49 61.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.11 41.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.748 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.2 t -54.43 -51.45 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.201 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.445 ' O ' HG23 ' B' ' 125' ' ' VAL . 65.2 t -58.27 -47.71 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.693 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -53.96 -63.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.084 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.63 -51.05 61.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.543 HD13 ' N ' ' B' ' 125' ' ' VAL . 1.4 tm? -52.36 -60.58 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.543 ' N ' HD13 ' B' ' 124' ' ' LEU . 97.4 t -58.33 -38.13 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.64 67.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.051 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -77.23 -47.33 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.536 HD13 HD22 ' B' ' 124' ' ' LEU . 1.8 mp -73.6 -31.97 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.92 -59.14 2.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 33' ' ' TRP . 13.3 t80 -53.05 -29.04 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -69.22 -60.42 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.948 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -59.36 -25.29 64.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.813 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' TRP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 20.3 m95 -86.45 -14.71 42.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -75.71 -28.86 58.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.93 -30.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.81 91.16 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.14 -175.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.92 -175.89 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.94 31.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.847 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 60.25 175.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.42 117.49 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.132 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -121.31 179.68 4.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.94 -66.39 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m 64.1 45.21 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.064 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 p -89.01 -46.78 8.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.41 112.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.85 25.45 14.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.843 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.3 -42.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 4.7 mt -69.42 -57.27 7.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.541 0.686 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.0 Cg_endo -69.72 -45.98 1.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.662 2.242 . . . . 0.0 112.414 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 16' ' ' ILE . 4.6 p -51.29 -28.28 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -49.58 69.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -29.47 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -74.92 -50.52 16.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 12' ' ' VAL . 49.6 mt -66.47 -38.18 81.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.141 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -68.15 -56.08 10.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.4 -44.1 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.36 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.695 HG12 HD12 ' A' ' 24' ' ' LEU . 46.6 t -52.66 -35.16 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.2 t -72.4 -50.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.842 HG22 HG22 ' B' ' 122' ' ' VAL . 87.2 t -51.76 -58.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.56 -56.24 26.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.472 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.733 ' O ' HD12 ' A' ' 28' ' ' ILE . 41.4 mt -50.92 -61.73 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.943 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 21' ' ' VAL . 67.8 t -53.59 -32.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' HB2' ' CH2' ' B' ' 133' ' ' TRP . . . -73.23 -32.77 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' B' ' 137' ' ' LYS . 60.4 t80 -73.61 -34.37 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.733 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.24 -54.27 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.12 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' B' ' 133' ' ' TRP . 22.0 t80 -44.73 -58.98 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -37.91 64.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.96 -26.02 64.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -21.1 29.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -45.29 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -67.23 -26.67 66.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.5 103.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.57 169.46 17.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 61.62 99.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -175.67 177.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -179.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.32 116.86 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 41.0 mtt-85 -121.88 179.99 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.53 -66.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.3 m 63.92 45.44 4.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 0.0 111.124 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.4 p -88.97 -46.74 8.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.24 112.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.91 25.45 13.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.939 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.29 -41.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 4.6 mt -69.47 -57.19 7.24 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.642 0.734 . . . . 0.0 111.108 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.1 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.735 2.29 . . . . 0.0 112.352 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 4.8 p -50.97 -28.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -49.42 74.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -31.73 72.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -73.06 -49.61 27.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.715 ' O ' HG23 ' B' ' 120' ' ' VAL . 33.4 mt -62.24 -33.98 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.527 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -67.03 -58.52 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.694 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.04 -43.04 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -57.71 11.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.4 t -53.59 -35.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.1 t -72.05 -51.39 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.175 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.842 HG22 HG22 ' A' ' 22' ' ' VAL . 94.2 t -51.35 -58.96 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.7 -56.28 25.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.747 ' O ' HD12 ' B' ' 128' ' ' ILE . 40.7 mt -50.96 -61.99 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.493 HG23 ' O ' ' B' ' 121' ' ' VAL . 76.0 t -52.67 -31.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.93 -30.97 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.09 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -79.03 -35.48 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.747 HD12 ' O ' ' B' ' 124' ' ' LEU . 2.9 mp -83.4 -63.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 125' ' ' VAL . . . -55.48 -62.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 10.3 t80 73.64 -59.41 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -35.24 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -24.68 47.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' TRP . . . . . 0.535 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 0.7 OUTLIER -84.64 -22.57 29.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASN . . . . . 0.485 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -86.62 -46.69 9.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.87 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 3.2 m -68.12 -26.11 65.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.9 103.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' LYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -137.17 169.24 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 61.24 99.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -175.51 177.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -179.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.9 p -118.38 142.65 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -162.33 -177.63 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.56 156.31 4.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.56 ' HB ' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -54.4 158.99 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 0.0 111.121 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -172.93 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 63.34 104.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 62.99 22.62 13.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.56 HD13 ' HB ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -124.18 -73.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.2 mp -72.46 -57.87 3.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.591 0.71 . . . . 0.0 111.109 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.2 Cg_endo -69.71 -5.68 16.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.381 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.4 p -50.07 -28.3 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -68.75 -49.94 54.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.02 -32.23 73.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -73.24 -52.84 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 20' ' ' VAL . 45.7 mt -65.5 -36.55 77.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 18' ' ' ALA . 5.5 tt -65.27 -57.25 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.52 -49.13 56.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.03 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 16' ' ' ILE . 63.4 t -54.51 -53.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.98 -51.86 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 18' ' ' ALA . 69.2 t -49.49 -58.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.44 58.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.456 ' HA ' HD13 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -61.28 -54.5 43.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 0.0 110.976 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.17 -32.75 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.76 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -76.64 -45.2 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.85 -53.58 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.81 -61.22 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -52.43 -29.99 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -75.97 -36.96 59.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -63.91 -38.63 91.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.485 ' CD2' ' CZ ' ' B' ' 130' ' ' PHE . 1.5 m-90 -86.79 -16.03 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -58.5 -45.87 87.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.7 t -147.1 -40.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.64 156.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.73 75.38 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.04 -39.5 92.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.9 95.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 166.38 33.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 43.3 p -118.19 142.88 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -162.08 -177.83 6.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.64 156.02 4.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.541 ' HB ' HD13 ' B' ' 109' ' ' LEU . 0.1 OUTLIER -54.4 159.27 2.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 111.162 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.84 -173.0 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.098 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.33 105.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 63.12 22.68 13.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.541 HD13 ' HB ' ' B' ' 105' ' ' THR . 0.1 OUTLIER -124.36 -73.4 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 1.2 mp -72.66 -57.76 3.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.596 0.712 . . . . 0.0 111.149 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.0 Cg_endo -69.91 -5.47 16.37 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.588 2.192 . . . . 0.0 112.345 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.548 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.98 -28.47 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.82 -50.29 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -69.95 -53.43 17.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.729 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.98 -32.64 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -64.29 0.9 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.669 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -48.41 -45.94 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -54.22 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 116' ' ' ILE . 57.6 t -54.9 -52.57 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 22' ' ' VAL . 59.9 t -57.88 -44.08 85.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.669 HG23 ' O ' ' B' ' 118' ' ' ALA . 53.8 t -56.5 -63.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.21 95.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.485 HD13 ' N ' ' B' ' 125' ' ' VAL . 1.9 tm? -58.21 -61.83 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.485 ' N ' HD13 ' B' ' 124' ' ' LEU . 88.1 t -57.13 -33.46 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.059 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.64 -25.15 60.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -77.06 -45.86 25.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.466 HD11 HD21 ' B' ' 124' ' ' LEU . 9.0 mt -74.77 -53.98 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.0 -61.16 2.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 33' ' ' TRP . 20.4 t80 -51.95 -30.05 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.16 -37.07 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -63.74 -38.44 91.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -87.31 -2.04 58.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -51.9 -32.89 34.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 22.1 t -125.27 -36.25 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.39 156.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.13 75.3 1.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.03 92.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.99 95.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.05 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.794 0.33 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.99 179.55 6.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -64.14 -26.65 68.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.81 10.14 21.63 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.496 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m 51.39 80.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.156 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.65 -72.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 54.26 24.3 4.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.556 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.2 m-20 -168.87 27.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 8' ' ' ASN . 2.3 mp -149.19 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mt -70.23 -57.97 5.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.559 0.695 . . . . 0.0 111.129 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.3 Cg_endo -69.76 -35.97 11.66 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.304 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -55.76 -21.89 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.74 -49.78 28.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -27.48 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.8 m -77.14 -51.5 10.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.691 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.9 mt -67.18 -40.56 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.5 -55.25 18.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.45 -47.82 56.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.07 -56.54 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 16' ' ' ILE . 43.5 t -53.15 -35.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 17' ' ' LEU . 99.7 t -73.36 -45.91 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.958 HG22 HG22 ' B' ' 122' ' ' VAL . 57.8 t -55.1 -59.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA2' ' CE3' ' B' ' 133' ' ' TRP . . . -59.79 -51.45 58.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 28' ' ' ILE . 55.1 tp -51.7 -61.94 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.377 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' VAL . 70.2 t -54.25 -34.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.04 -29.72 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -75.82 -35.06 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.707 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -81.06 -45.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.92 -61.18 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -44.76 -54.84 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.1 -44.19 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -59.78 -26.26 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -86.53 -17.56 33.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.95 -37.61 84.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.9 -34.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.43 103.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 175.52 9.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.02 86.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -158.63 82.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.67 164.43 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.81 178.66 7.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.145 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.19 -27.14 68.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 10.66 21.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.545 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 3.3 m 53.41 79.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.427 HG21 HD12 ' B' ' 110' ' ' ILE . 0.2 OUTLIER -162.0 -74.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.24 21.8 3.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ASN . . . . . 0.675 ' C ' HD12 ' B' ' 109' ' ' LEU . 1.1 m-20 178.62 30.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.675 HD12 ' C ' ' B' ' 108' ' ' ASN . 6.5 mp -141.66 -58.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 3.0 mt -73.04 -58.2 2.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.695 0.759 . . . . 0.0 111.159 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.3 Cg_endo -69.74 -38.25 8.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.639 2.226 . . . . 0.0 112.324 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.677 HG22 HD11 ' B' ' 116' ' ' ILE . 4.4 p -52.69 -26.69 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.45 -49.46 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -30.73 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 52.8 m -73.66 -50.52 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.725 ' O ' HG23 ' B' ' 120' ' ' VAL . 41.1 mt -61.62 -35.93 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.435 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -65.76 -56.88 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.756 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.19 -47.26 54.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.74 -56.5 18.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.0 t -52.53 -35.67 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.483 ' O ' HG23 ' B' ' 125' ' ' VAL . 93.8 t -73.53 -44.92 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 22' ' ' VAL . 61.0 t -55.36 -59.88 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.11 -50.17 70.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.722 ' O ' HD12 ' B' ' 128' ' ' ILE . 57.2 tp -53.19 -62.41 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 121' ' ' VAL . 65.9 t -54.77 -36.1 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.65 62.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.71 -33.54 40.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.722 HD12 ' O ' ' B' ' 124' ' ' LEU . 2.9 mp -76.76 -63.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.11 -64.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 3.0 t80 71.77 -62.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -42.53 87.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -56.96 -24.09 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' TRP . . . . . 0.495 ' CE3' ' HA2' ' A' ' 23' ' ' GLY . 2.8 m95 -99.14 -9.69 23.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.37 -34.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.5 103.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.86 174.57 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.83 86.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -158.54 83.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.54 164.27 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.951 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.21 137.78 44.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -154.15 127.71 8.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.1 35.01 1.95 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.7 p -59.6 -171.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.604 ' CG2' HD22 ' A' ' 9' ' ' LEU . 0.3 OUTLIER 64.42 104.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -94.0 141.27 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.33 16.22 9.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD22 ' CG2' ' A' ' 6' ' ' THR . 2.3 mp -121.91 -73.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.2 mt -70.56 -57.66 5.28 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.8 Cg_endo -69.79 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 16' ' ' ILE . 3.4 p -49.37 -28.94 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -60.32 -46.86 88.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.74 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -46.08 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.791 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.3 mt -63.27 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 8.2 tp -53.76 -60.2 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.04 -50.05 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.64 63.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 16' ' ' ILE . 47.8 t -58.04 -51.52 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.7 t -57.81 -48.34 83.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 18' ' ' ALA . 85.1 t -53.68 -63.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.44 -51.78 56.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.544 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 28' ' ' ILE . 1.3 tm? -52.0 -60.59 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 24' ' ' LEU . 94.2 t -58.22 -38.05 66.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.99 67.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -77.02 -47.31 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.5 -32.22 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.03 -61.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -54.62 -30.25 54.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -80.29 -51.73 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -36.79 51.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.625 ' HB3' ' CE1' ' B' ' 130' ' ' PHE . 5.9 m0 -86.07 -20.92 28.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.26 -45.26 49.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -69.97 -26.42 64.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 -40.01 61.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.803 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.59 -178.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 55.26 57.85 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.09 170.65 16.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 140.11 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.832 0.349 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.11 138.09 45.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.132 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -154.16 127.26 8.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.05 34.44 1.93 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.477 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 29.2 p -59.63 -171.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' THR . . . . . 0.683 HG22 ' HB2' ' B' ' 109' ' ' LEU . 0.2 OUTLIER 61.71 104.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.1 135.1 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.18 14.87 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.683 ' HB2' HG22 ' B' ' 106' ' ' THR . 9.4 mp -118.13 -56.51 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 5.2 mt -70.32 -57.61 5.65 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.181 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.2 Cg_endo -69.82 -5.17 15.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.687 HG22 HD11 ' B' ' 116' ' ' ILE . 3.0 p -49.46 -29.26 3.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.44 -49.6 75.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.967 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' CYS . . . . . 0.495 ' HA ' ' CD2' ' B' ' 117' ' ' LEU . 0.1 OUTLIER -68.72 -42.04 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.857 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -37.52 85.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.687 HD11 HG22 ' B' ' 112' ' ' VAL . 45.0 mt -75.24 -55.29 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 121' ' ' VAL . 3.5 pp -58.48 -39.34 79.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.644 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -64.92 -50.57 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.47 68.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 116' ' ' ILE . 41.7 t -63.14 -51.33 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.6 t -57.71 -48.73 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.644 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -53.55 -63.49 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.37 -51.77 56.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.56 HD13 ' N ' ' B' ' 125' ' ' VAL . 1.3 tm? -51.83 -60.74 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.56 ' N ' HD13 ' B' ' 124' ' ' LEU . 99.8 t -58.12 -38.04 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.118 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.38 -26.92 67.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -76.99 -47.29 21.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.542 HD13 HD22 ' B' ' 124' ' ' LEU . 1.8 mp -73.79 -31.96 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.31 -60.63 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.625 ' CE1' ' HB3' ' A' ' 33' ' ' TRP . 12.4 t80 -52.39 -30.61 29.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -80.06 -50.77 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.44 -36.58 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -85.57 -21.22 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.41 -45.3 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -70.1 -26.59 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -39.41 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.84 -178.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 55.24 57.39 5.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.46 170.76 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.95 140.04 32.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.907 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.465 -0.164 0 CA-C-O 120.804 0.251 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.531 HG22 HD12 ' A' ' 16' ' ' ILE . 7.7 p -79.53 -36.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -49.29 47.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.43 -28.3 69.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 m -77.13 -52.27 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 20' ' ' VAL . 75.0 mt -65.13 -37.96 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -66.92 -57.26 7.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.57 -38.62 55.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.41 20.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -57.93 -40.71 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 17' ' ' LEU . 61.7 t -61.86 -58.5 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.6 t -52.06 -60.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.33 -48.18 54.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 28' ' ' ILE . 54.9 tp -51.7 -61.8 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' VAL . 44.5 t -52.37 -32.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.56 69.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -66.41 -34.97 79.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.3 -39.68 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.99 64.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.98 -26.38 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.57 -45.98 15.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.799 0.249 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.541 HG22 HD12 ' B' ' 116' ' ' ILE . 7.6 p -79.51 -36.18 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.174 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.43 -49.48 41.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.57 -28.25 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.4 m -77.02 -51.97 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.645 ' O ' HG23 ' B' ' 120' ' ' VAL . 75.8 mt -65.5 -38.12 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.671 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -66.71 -57.67 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.51 -38.79 55.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.64 18.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.4 t -57.44 -40.13 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 117' ' ' LEU . 57.4 t -62.55 -58.52 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -51.75 -61.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.18 -48.52 52.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 tp . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.896 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.848 0.27 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.696 HG22 HD11 ' A' ' 16' ' ' ILE . 2.9 p -51.31 -27.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.93 -49.41 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.72 -31.14 71.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -49.19 22.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.955 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 20' ' ' VAL . 43.0 mt -65.79 -38.62 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.81 8.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.23 -45.13 61.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -54.52 39.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 16' ' ' ILE . 26.3 t -55.07 -48.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.44 -53.24 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' ALA . 98.9 t -50.69 -61.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.83 49.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -55.49 -55.56 30.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 122' ' ' VAL . 62.0 t -58.65 -33.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -27.51 60.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -74.01 -45.38 50.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.429 HD11 HD23 ' A' ' 24' ' ' LEU . 4.4 mt -74.42 -47.42 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -59.84 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -51.92 -30.39 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.29 -42.85 35.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.817 0.257 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.719 HG22 HD11 ' B' ' 116' ' ' ILE . 2.9 p -51.39 -27.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.85 -49.44 70.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 t -65.8 -31.59 72.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -49.07 25.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.731 ' O ' HG23 ' B' ' 120' ' ' VAL . 42.3 mt -65.73 -38.22 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -57.72 9.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.657 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.24 -45.86 62.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.116 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.27 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 116' ' ' ILE . 26.0 t -54.97 -50.05 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.07 -52.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.657 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -51.64 -63.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.05 89.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.864 0.277 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.656 HG22 ' CD1' ' A' ' 16' ' ' ILE . 2.8 p -50.26 -28.12 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.39 -49.39 71.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -64.09 -32.45 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.9 m -74.59 -50.83 16.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.6 mt -65.55 -37.84 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -63.76 -56.7 13.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.41 -47.56 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.23 -53.25 53.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.139 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 38.4 t -57.74 -51.65 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' LEU . 62.1 t -55.61 -55.26 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.1 t -50.56 -60.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.84 -39.78 48.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.55 -57.17 13.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.9 t -57.9 -32.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.98 -27.01 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -74.54 -45.73 43.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.436 HD11 HD23 ' A' ' 24' ' ' LEU . 4.2 mt -73.13 -46.31 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -61.18 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -52.17 -52.21 53.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -53.71 -37.28 63.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.819 0.258 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' B' ' 116' ' ' ILE . 2.8 p -50.24 -28.27 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.26 -49.36 72.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.03 -32.47 74.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.0 m -74.53 -50.94 16.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.726 ' O ' HG23 ' B' ' 120' ' ' VAL . 55.8 mt -65.32 -37.43 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.413 ' O ' HG23 ' B' ' 121' ' ' VAL . 1.0 OUTLIER -64.03 -56.41 15.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.647 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.47 -47.46 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.57 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 116' ' ' ILE . 34.6 t -56.52 -50.91 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.413 HG23 ' O ' ' B' ' 117' ' ' LEU . 61.4 t -56.66 -53.45 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 118' ' ' ALA . 99.0 t -51.06 -63.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.55 -42.93 85.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.82 0.258 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.3 p -49.66 -28.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -68.87 -49.93 54.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -63.43 -32.33 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 m -73.56 -53.6 10.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.707 ' O ' HG23 ' A' ' 20' ' ' VAL . 44.2 mt -64.34 -36.94 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.154 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 5.7 tt -66.42 -56.46 10.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.504 ' N ' HD23 ' A' ' 17' ' ' LEU . . . -49.88 -45.6 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -55.22 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 16' ' ' ILE . 54.6 t -55.92 -44.68 78.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.5 t -56.7 -59.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' B' ' 121' ' ' VAL . 65.8 t -51.34 -63.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.67 -41.88 51.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.572 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -61.61 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.85 -30.01 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.53 50.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -74.86 -43.79 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.4 -46.56 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.07 -59.53 5.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -51.65 -40.1 59.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -29.16 64.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.808 0.253 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.565 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.62 -28.66 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.159 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -67.9 -50.24 57.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.23 -33.84 76.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -69.46 -53.84 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.734 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.18 -31.84 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.142 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -64.71 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.563 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -49.48 -40.56 37.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.59 -54.41 46.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 116' ' ' ILE . 40.7 t -58.46 -49.16 83.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.087 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 22' ' ' VAL . 85.5 t -58.07 -56.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 118' ' ' ALA . 71.7 t -49.03 -60.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.66 -39.1 45.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.141 0 CA-C-O 120.86 0.275 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -50.43 -27.89 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.11 -49.43 72.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.08 -32.22 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -51.58 14.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.825 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 12' ' ' VAL . 36.4 mt -62.65 -37.82 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -64.44 -55.63 19.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.59 -48.01 57.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -52.89 62.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 16' ' ' ILE . 46.6 t -60.03 -30.9 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 17' ' ' LEU . 88.9 t -71.55 -57.69 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.054 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.643 HG22 HG22 ' B' ' 122' ' ' VAL . 82.6 t -51.69 -57.63 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.76 -49.32 66.63 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 28' ' ' ILE . 40.0 tp -51.91 -61.28 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.362 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 21' ' ' VAL . 47.4 t -51.43 -31.67 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -39.38 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.56 -35.94 82.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 24' ' ' LEU . 3.4 mt -83.58 -39.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.88 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.41 -30.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -71.38 -58.88 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.807 0.253 . . . . 0.0 112.306 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 2.8 p -50.52 -27.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.046 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.06 -49.38 72.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.03 -32.51 74.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -51.34 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.712 HD11 HG22 ' B' ' 112' ' ' VAL . 36.4 mt -62.69 -37.93 80.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.162 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.691 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -64.19 -56.0 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.34 -48.1 55.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.05 -52.36 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.8 t -60.78 -31.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 117' ' ' LEU . 90.1 t -71.07 -58.19 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 22' ' ' VAL . 89.9 t -51.58 -57.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -48.73 67.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.549 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 44.4 tp . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.14 0 CA-C-O 120.792 0.247 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.5 p -48.88 -29.15 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.32 -49.31 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.23 -33.19 75.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.21 -50.77 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.4 mt -65.11 -38.89 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.159 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.0 -56.98 13.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.34 -48.26 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.82 -53.1 43.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -54.36 -51.56 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.4 t -58.07 -47.84 85.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' ALA . 97.8 t -53.82 -63.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.94 62.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 25' ' ' VAL . 1.3 tm? -52.53 -60.48 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 24' ' ' LEU . 98.3 t -58.48 -37.91 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -26.86 67.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.16 -47.21 20.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.72 -32.13 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.22 3.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -53.5 -28.15 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -68.98 -58.77 3.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 CA-C-O 120.822 0.259 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -48.75 -29.04 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.189 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.45 -49.43 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.29 -33.02 74.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -73.36 -50.64 20.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.748 ' O ' HG23 ' B' ' 120' ' ' VAL . 53.6 mt -65.37 -38.68 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -57.23 12.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.693 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.11 -48.49 61.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.11 41.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.748 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.2 t -54.43 -51.45 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.201 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.27 -47.71 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.693 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -53.96 -63.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.084 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.63 -51.05 61.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.448 HD22 ' O ' ' B' ' 124' ' ' LEU . 1.4 tm? . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.173 0 CA-C-O 120.885 0.285 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 16' ' ' ILE . 4.6 p -51.29 -28.28 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -49.58 69.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -29.47 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -74.92 -50.52 16.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 12' ' ' VAL . 49.6 mt -66.47 -38.18 81.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.141 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -68.15 -56.08 10.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.4 -44.1 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.36 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.695 HG12 HD12 ' A' ' 24' ' ' LEU . 46.6 t -52.66 -35.16 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.2 t -72.4 -50.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.842 HG22 HG22 ' B' ' 122' ' ' VAL . 87.2 t -51.76 -58.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.56 -56.24 26.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.472 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.733 ' O ' HD12 ' A' ' 28' ' ' ILE . 41.4 mt -50.92 -61.73 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.943 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 21' ' ' VAL . 67.8 t -53.59 -32.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.23 -32.77 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -73.61 -34.37 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.733 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.24 -54.27 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.12 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -44.73 -58.98 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -37.91 64.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.854 0.272 . . . . 0.0 112.352 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 4.8 p -50.97 -28.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -49.42 74.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -31.73 72.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -73.06 -49.61 27.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.715 ' O ' HG23 ' B' ' 120' ' ' VAL . 33.4 mt -62.24 -33.98 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.527 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -67.03 -58.52 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.694 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.04 -43.04 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -57.71 11.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.4 t -53.59 -35.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.1 t -72.05 -51.39 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.175 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.842 HG22 HG22 ' A' ' 22' ' ' VAL . 94.2 t -51.35 -58.96 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.7 -56.28 25.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.696 HD12 HG12 ' B' ' 120' ' ' VAL . 40.7 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.222 0 CA-C-O 120.808 0.253 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.4 p -50.07 -28.3 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -68.75 -49.94 54.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.02 -32.23 73.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -73.24 -52.84 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 20' ' ' VAL . 45.7 mt -65.5 -36.55 77.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 18' ' ' ALA . 5.5 tt -65.27 -57.25 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.52 -49.13 56.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.03 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 16' ' ' ILE . 63.4 t -54.51 -53.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.98 -51.86 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 18' ' ' ALA . 69.2 t -49.49 -58.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.44 58.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -61.28 -54.5 43.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 0.0 110.976 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.17 -32.75 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.76 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -76.64 -45.2 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.85 -53.58 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.81 -61.22 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -52.43 -29.99 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -75.97 -36.96 59.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.85 0.271 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.548 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.98 -28.47 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.82 -50.29 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -69.95 -53.43 17.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.729 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.98 -32.64 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -64.29 0.9 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.669 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -48.41 -45.94 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -54.22 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 116' ' ' ILE . 57.6 t -54.9 -52.57 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 22' ' ' VAL . 59.9 t -57.88 -44.08 85.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.669 HG23 ' O ' ' B' ' 118' ' ' ALA . 53.8 t -56.5 -63.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.21 95.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.452 HD13 ' C ' ' B' ' 124' ' ' LEU . 1.9 tm? . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.848 0.27 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -55.76 -21.89 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.74 -49.78 28.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -27.48 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.8 m -77.14 -51.5 10.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.691 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.9 mt -67.18 -40.56 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.5 -55.25 18.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.45 -47.82 56.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.07 -56.54 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 16' ' ' ILE . 43.5 t -53.15 -35.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 17' ' ' LEU . 99.7 t -73.36 -45.91 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.958 HG22 HG22 ' B' ' 122' ' ' VAL . 57.8 t -55.1 -59.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.45 58.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 28' ' ' ILE . 55.1 tp -51.7 -61.94 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.377 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' VAL . 70.2 t -54.25 -34.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.04 -29.72 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -75.82 -35.06 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.707 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -81.06 -45.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.92 -61.18 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -44.76 -54.84 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.1 -44.19 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.768 0.237 . . . . 0.0 112.324 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.677 HG22 HD11 ' B' ' 116' ' ' ILE . 4.4 p -52.69 -26.69 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.45 -49.46 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -30.73 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 52.8 m -73.66 -50.52 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.725 ' O ' HG23 ' B' ' 120' ' ' VAL . 41.1 mt -61.62 -35.93 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.435 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -65.76 -56.88 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.756 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.19 -47.26 54.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.74 -56.5 18.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.0 t -52.53 -35.67 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.8 t -73.53 -44.92 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 22' ' ' VAL . 61.0 t -55.36 -59.88 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.11 -50.17 70.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.917 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.849 0.27 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 16' ' ' ILE . 3.4 p -49.37 -28.94 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -60.32 -46.86 88.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.74 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -46.08 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.791 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.3 mt -63.27 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 8.2 tp -53.76 -60.2 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.04 -50.05 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.64 63.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 16' ' ' ILE . 47.8 t -58.04 -51.52 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.7 t -57.81 -48.34 83.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 18' ' ' ALA . 85.1 t -53.68 -63.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.44 -51.78 56.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.544 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 28' ' ' ILE . 1.3 tm? -52.0 -60.59 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 24' ' ' LEU . 94.2 t -58.22 -38.05 66.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.99 67.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -77.02 -47.31 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.5 -32.22 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.03 -61.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -54.62 -30.25 54.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -80.29 -51.73 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.841 0.267 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.687 HG22 HD11 ' B' ' 116' ' ' ILE . 3.0 p -49.46 -29.26 3.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.44 -49.6 75.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.967 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' CYS . . . . . 0.495 ' HA ' ' CD2' ' B' ' 117' ' ' LEU . 0.1 OUTLIER -68.72 -42.04 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.857 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -37.52 85.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.687 HD11 HG22 ' B' ' 112' ' ' VAL . 45.0 mt -75.24 -55.29 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 121' ' ' VAL . 3.5 pp -58.48 -39.34 79.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ALA . . . . . 0.644 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -64.92 -50.57 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.47 68.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 116' ' ' ILE . 41.7 t -63.14 -51.33 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.6 t -57.71 -48.73 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.644 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -53.55 -63.49 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.37 -51.77 56.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.463 HD22 ' O ' ' B' ' 124' ' ' LEU . 1.3 tm? . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.93 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.887 0.375 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.2 p -82.77 -35.39 26.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 52.93 51.66 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.92 5.84 83.11 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.12 34.83 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.803 0.335 . . . . 0.0 111.143 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.731 ' HB ' HD12 ' A' ' 10' ' ' ILE . 6.2 t -88.31 -25.13 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.3 74.24 0.23 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.77 89.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.866 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.478 HD23 ' N ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -176.91 -74.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.731 HD12 ' HB ' ' A' ' 6' ' ' THR . 3.9 mt -47.12 -58.62 6.81 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.636 0.731 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.676 ' CD ' HG21 ' A' ' 6' ' ' THR . 54.3 Cg_endo -69.69 52.54 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.7 2.266 . . . . 0.0 112.387 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.531 HG22 HD12 ' A' ' 16' ' ' ILE . 7.7 p -79.53 -36.17 17.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.96 -49.29 47.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.43 -28.3 69.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.4 m -77.13 -52.27 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 20' ' ' VAL . 75.0 mt -65.13 -37.96 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.13 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -66.92 -57.26 7.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.57 -38.62 55.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.55 -56.41 20.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.102 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -57.93 -40.71 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 17' ' ' LEU . 61.7 t -61.86 -58.5 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.6 t -52.06 -60.89 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.33 -48.18 54.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.717 ' O ' HD12 ' A' ' 28' ' ' ILE . 54.9 tp -51.7 -61.8 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.937 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 21' ' ' VAL . 44.5 t -52.37 -32.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.15 -38.56 69.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -66.41 -34.97 79.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.3 -39.68 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.99 64.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.085 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.98 -26.38 66.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.57 -45.98 15.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -64.32 -30.9 71.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -86.25 -17.28 35.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -55.22 -25.87 35.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.57 -34.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.66 146.6 7.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.784 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.39 175.18 7.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.9 -60.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 55.99 65.64 1.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? 61.01 97.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.869 0.366 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 81.2 p -83.06 -36.13 25.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 52.18 51.39 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.16 7.74 79.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.56 29.96 6.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.174 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 2.2 t -94.71 -19.38 20.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.12 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 50.18 83.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.46 93.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -161.04 -62.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 3.6 mt -50.33 -58.71 8.9 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 111.132 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.4 Cg_endo -69.81 53.09 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.319 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.541 HG22 HD12 ' B' ' 116' ' ' ILE . 7.6 p -79.51 -36.18 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.174 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.43 -49.48 41.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.57 -28.25 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 9.4 m -77.02 -51.97 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.645 ' O ' HG23 ' B' ' 120' ' ' VAL . 75.8 mt -65.5 -38.12 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.671 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -66.71 -57.67 6.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.903 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.641 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.51 -38.79 55.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.106 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.13 -56.64 18.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.4 t -57.44 -40.13 72.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.159 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.671 HG23 ' O ' ' B' ' 117' ' ' LEU . 57.4 t -62.55 -58.52 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.641 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -51.75 -61.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.18 -48.52 52.94 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.5 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.732 ' O ' HD12 ' B' ' 128' ' ' ILE . 54.8 tp -51.7 -61.85 1.99 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 121' ' ' VAL . 44.7 t -52.44 -32.88 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.107 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.97 -38.7 69.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -66.37 -35.07 79.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.732 HD12 ' O ' ' B' ' 124' ' ' LEU . 2.9 mp -84.21 -39.74 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.155 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.94 -47.95 64.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -66.87 -26.34 66.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.95 -45.81 14.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -63.94 -29.92 71.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -86.87 -16.46 35.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -56.02 -25.5 44.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.917 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.48 -34.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.83 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.92 146.86 7.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.806 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.87 174.79 7.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -96.09 -60.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 56.25 65.51 1.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? 61.19 97.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.87 0.367 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.623 ' OG1' HG21 ' B' ' 102' ' ' THR . 0.2 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.156 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.68 -74.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 52.02 27.84 23.36 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.509 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -29.71 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.137 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.643 HG22 ' HB2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -71.84 131.66 43.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.155 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -122.22 -65.47 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -95.66 24.41 5.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.643 ' HB2' HG22 ' A' ' 6' ' ' THR . 10.7 mp -117.01 -33.76 4.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 mt -70.01 -57.19 6.47 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.539 0.685 . . . . 0.0 111.156 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.2 Cg_endo -69.75 -45.29 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.685 2.257 . . . . 0.0 112.345 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.696 HG22 HD11 ' A' ' 16' ' ' ILE . 2.9 p -51.31 -27.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.93 -49.41 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 t -65.72 -31.14 71.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.66 -49.19 22.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.955 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.721 ' O ' HG23 ' A' ' 20' ' ' VAL . 43.0 mt -65.79 -38.62 82.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.97 -57.81 8.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.23 -45.13 61.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -54.52 39.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 16' ' ' ILE . 26.3 t -55.07 -48.51 75.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.149 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.2 t -59.44 -53.24 51.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 18' ' ' ALA . 98.9 t -50.69 -61.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.83 49.51 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD23 HD11 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -55.49 -55.56 30.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.591 HG21 HG11 ' B' ' 122' ' ' VAL . 62.0 t -58.65 -33.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.51 -27.51 60.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -74.01 -45.38 50.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.429 HD11 HD23 ' A' ' 24' ' ' LEU . 4.4 mt -74.42 -47.42 40.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.88 -59.84 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -51.92 -30.39 24.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.29 -42.85 35.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -59.91 -26.24 65.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.413 ' CE2' ' CE1' ' B' ' 130' ' ' PHE . 75.4 m95 -79.35 -21.31 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -40.52 70.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 m -94.26 9.27 38.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.814 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -93.03 43.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.821 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.56 -170.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.454 ' NE2' ' HG3' ' B' ' 138' ' ' GLN . 13.6 tm0? -132.73 111.04 10.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -106.34 101.52 10.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.56 103.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 41.1 mtt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.892 0.377 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.623 HG21 ' OG1' ' A' ' 2' ' ' THR . 0.2 OUTLIER -136.91 -172.66 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.173 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -74.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 52.01 27.91 23.5 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.73 -29.71 19.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 111.153 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.657 HG22 ' HB2' ' B' ' 109' ' ' LEU . 0.1 OUTLIER -71.69 131.68 43.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -122.27 -65.45 1.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.447 ' C ' HD12 ' B' ' 109' ' ' LEU . 0.8 OUTLIER -95.82 24.48 5.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.657 ' HB2' HG22 ' B' ' 106' ' ' THR . 10.6 mp -117.03 -33.6 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 2.5 mt -70.08 -57.34 6.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.62 0.724 . . . . 0.0 111.155 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.2 Cg_endo -69.81 -45.0 1.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.229 . . . . 0.0 112.297 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.719 HG22 HD11 ' B' ' 116' ' ' ILE . 2.9 p -51.39 -27.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -64.85 -49.44 70.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 3.4 t -65.8 -31.59 72.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.09 -49.07 25.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.731 ' O ' HG23 ' B' ' 120' ' ' VAL . 42.3 mt -65.73 -38.22 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.52 -57.72 9.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.657 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.24 -45.86 62.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.116 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.27 40.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.731 HG23 ' O ' ' B' ' 116' ' ' ILE . 26.0 t -54.97 -50.05 65.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.158 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 125' ' ' VAL . 99.0 t -58.07 -52.04 63.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.657 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -51.64 -63.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.57 -46.05 89.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.484 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.94 -56.39 18.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 110.987 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 121' ' ' VAL . 47.1 t -57.83 -32.44 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.47 60.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -73.52 -45.08 55.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.38 -47.35 40.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.12 -59.88 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.14 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.413 ' CE1' ' CE2' ' A' ' 33' ' ' TRP . 18.0 t80 -51.89 -30.22 23.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.883 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -42.74 39.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.925 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -59.45 -26.35 65.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -79.19 -21.27 46.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.989 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -40.52 70.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 3.0 m -94.03 9.52 37.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -92.98 43.93 1.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.84 -170.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . 0.454 ' HG3' ' NE2' ' A' ' 38' ' ' GLN . 13.5 tm0? -132.66 111.22 11.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.932 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -106.35 101.77 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.973 0.416 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 103.72 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.945 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.855 0.36 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.99 110.66 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.143 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -144.24 40.04 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.75 -20.28 63.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.449 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.16 41.83 23.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.0 111.156 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.72 -46.78 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.147 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 50.13 27.97 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.56 32.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.58 -74.92 0.14 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mt -71.58 -57.75 4.11 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.647 0.737 . . . . 0.0 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.6 Cg_endo -69.77 -5.71 16.87 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.746 2.297 . . . . 0.0 112.335 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.656 HG22 ' CD1' ' A' ' 16' ' ' ILE . 2.8 p -50.26 -28.12 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.39 -49.39 71.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 t -64.09 -32.45 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.865 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.9 m -74.59 -50.83 16.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.6 mt -65.55 -37.84 80.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -63.76 -56.7 13.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.973 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.63 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.41 -47.56 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.23 -53.25 53.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.139 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 16' ' ' ILE . 38.4 t -57.74 -51.65 67.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' LEU . 62.1 t -55.61 -55.26 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.139 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 18' ' ' ALA . 95.1 t -50.56 -60.8 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.84 -39.78 48.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.521 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.436 HD23 HD11 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -56.55 -57.17 13.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.957 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.9 t -57.9 -32.28 42.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.98 -27.01 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.042 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -74.54 -45.73 43.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.901 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.436 HD11 HD23 ' A' ' 24' ' ' LEU . 4.2 mt -73.13 -46.31 51.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.61 -61.18 2.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.116 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -52.17 -52.21 53.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -53.71 -37.28 63.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -57.39 -26.03 60.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.34 -17.46 34.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.936 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.66 -45.6 78.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.845 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.8 p -86.69 -37.66 17.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 m -51.7 -30.5 22.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 94.85 3.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.63 70.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -169.27 86.7 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.31 84.85 2.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.885 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.871 0.367 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.01 110.84 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.117 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -144.08 40.02 1.35 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.72 -20.53 63.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.487 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.17 41.6 23.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 111.18 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.91 -46.96 2.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 50.21 27.87 2.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.871 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.31 31.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.57 -74.79 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 2.1 mt -71.62 -57.79 4.06 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.711 0.767 . . . . 0.0 111.204 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.2 Cg_endo -69.78 -5.69 16.83 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.645 2.23 . . . . 0.0 112.39 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.665 HG22 ' CD1' ' B' ' 116' ' ' ILE . 2.8 p -50.24 -28.27 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.26 -49.36 72.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.03 -32.47 74.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 6.0 m -74.53 -50.94 16.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.726 ' O ' HG23 ' B' ' 120' ' ' VAL . 55.8 mt -65.32 -37.43 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.413 ' O ' HG23 ' B' ' 121' ' ' VAL . 1.0 OUTLIER -64.03 -56.41 15.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.854 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.647 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.47 -47.46 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.57 49.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.726 HG23 ' O ' ' B' ' 116' ' ' ILE . 34.6 t -56.52 -50.91 70.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.414 ' O ' HG23 ' B' ' 125' ' ' VAL . 61.4 t -56.66 -53.45 41.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 118' ' ' ALA . 99.0 t -51.06 -63.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.55 -42.93 85.48 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.463 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -58.29 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 121' ' ' VAL . 59.6 t -57.43 -31.62 39.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.0 -27.38 57.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.017 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -74.53 -46.15 41.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.938 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.0 mt -73.28 -46.06 51.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.118 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.69 -61.03 2.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -52.1 -52.48 51.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.859 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -54.22 -37.58 64.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -57.51 -25.62 60.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.825 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.36 -12.55 22.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -69.74 -70.16 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 1.8 p -106.17 -45.09 4.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.68 -30.36 21.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 94.8 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.859 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.23 70.79 0.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -169.11 86.84 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.14 84.85 2.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.868 0.366 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.11 138.73 12.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -72.41 138.17 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.62 -20.02 9.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m 63.62 25.27 14.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.343 . . . . 0.0 111.155 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 136.93 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.201 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.612 ' O ' HD12 ' A' ' 9' ' ' LEU . 0.9 OUTLIER -107.26 88.5 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.16 22.93 13.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 7' ' ' ASP . 6.8 mp -89.14 -39.23 13.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.3 mt -71.36 -57.74 4.32 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 0.0 111.181 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.3 Cg_endo -69.8 -4.93 15.05 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.696 2.264 . . . . 0.0 112.325 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.3 p -49.66 -28.54 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -68.87 -49.93 54.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.4 t -63.43 -32.33 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.9 m -73.56 -53.6 10.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.707 ' O ' HG23 ' A' ' 20' ' ' VAL . 44.2 mt -64.34 -36.94 78.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.154 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 5.7 tt -66.42 -56.46 10.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.976 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.504 ' N ' HD23 ' A' ' 17' ' ' LEU . . . -49.88 -45.6 50.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -55.22 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.061 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 16' ' ' ILE . 54.6 t -55.92 -44.68 78.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.5 t -56.7 -59.37 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.099 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.502 HG21 ' CG1' ' B' ' 121' ' ' VAL . 65.8 t -51.34 -63.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.67 -41.88 51.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.572 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.61 -61.61 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.85 -30.01 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.72 -27.53 50.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -74.86 -43.79 52.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.4 -46.56 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.07 -59.53 5.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.139 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -51.65 -40.1 59.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -29.16 64.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -73.51 -41.36 63.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -86.19 -16.45 37.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -56.97 -45.54 82.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.0 p -152.3 -40.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -50.01 158.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.72 -32.04 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -162.2 131.72 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -127.56 -74.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.82 -169.71 3.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.2 mpp? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.838 0.351 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.29 138.72 12.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -72.28 138.08 47.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.77 -20.48 8.87 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.46 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.8 m 63.32 25.73 14.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.949 0.404 . . . . 0.0 111.213 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 137.56 44.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.617 ' H ' HD13 ' B' ' 109' ' ' LEU . 0.9 OUTLIER -107.41 88.64 2.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.14 22.96 13.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.617 HD13 ' H ' ' B' ' 107' ' ' ASP . 6.8 mp -89.1 -39.08 13.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 5.3 mt -71.48 -57.63 4.28 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.672 0.749 . . . . 0.0 111.204 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.8 Cg_endo -69.68 -4.95 15.0 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.367 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.565 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.62 -28.66 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.159 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -67.9 -50.24 57.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.3 t -64.23 -33.84 76.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.932 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 66.4 m -69.46 -53.84 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.734 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.18 -31.84 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.142 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -64.71 0.8 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.563 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -49.48 -40.56 37.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.09 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.59 -54.41 46.29 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 116' ' ' ILE . 40.7 t -58.46 -49.16 83.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.087 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.502 ' CG1' HG21 ' A' ' 22' ' ' VAL . 85.5 t -58.07 -56.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 118' ' ' ALA . 71.7 t -49.03 -60.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.66 -39.1 45.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.461 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -61.97 2.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.887 0.375 . . . . 0.0 110.864 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.24 -31.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.143 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.66 -26.55 54.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -75.34 -44.59 44.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.7 mt -75.13 -47.64 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.155 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.419 ' HB1' ' CZ3' ' B' ' 133' ' ' TRP . . . -57.82 -59.91 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -51.94 -39.02 58.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -30.06 66.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -72.68 -40.8 65.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.901 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . 0.419 ' CZ3' ' HB1' ' B' ' 129' ' ' ALA . 10.2 m0 -87.36 -2.51 58.67 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -53.27 -31.96 46.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 60.6 p -126.17 -36.88 2.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.4 t -51.07 156.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.918 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -119.82 -33.03 4.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -162.53 133.3 4.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.97 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -127.07 -74.21 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.6 -170.68 3.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 179.861 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.833 0.349 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.18 112.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.139 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.05 125.34 50.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.831 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.84 -30.23 0.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.4 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m 51.58 45.47 28.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 10' ' ' ILE . 6.9 t -103.36 -13.87 16.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.067 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.92 82.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.2 92.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.54 -64.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.59 ' H ' HG21 ' A' ' 6' ' ' THR . 2.9 mt -71.46 -57.68 4.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.634 0.73 . . . . 0.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.1 Cg_endo -69.83 -5.82 17.16 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.341 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -50.43 -27.89 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.11 -49.43 72.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.08 -32.22 73.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.4 -51.58 14.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.825 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.706 HD11 HG22 ' A' ' 12' ' ' VAL . 36.4 mt -62.65 -37.82 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.17 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.705 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -64.44 -55.63 19.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.59 -48.01 57.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -52.89 62.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.063 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 16' ' ' ILE . 46.6 t -60.03 -30.9 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 17' ' ' LEU . 88.9 t -71.55 -57.69 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.054 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.643 HG22 HG22 ' B' ' 122' ' ' VAL . 82.6 t -51.69 -57.63 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.76 -49.32 66.63 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.451 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 28' ' ' ILE . 40.0 tp -51.91 -61.28 2.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.362 . . . . 0.0 110.899 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 21' ' ' VAL . 47.4 t -51.43 -31.67 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -39.38 63.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.56 -35.94 82.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.904 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 24' ' ' LEU . 3.4 mt -83.58 -39.91 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.142 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.88 8.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.1 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.41 -30.08 4.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -71.38 -58.88 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.4 ptt180 -61.28 -26.74 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -20.57 32.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -88.07 -7.73 56.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.87 14.59 9.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.842 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -46.88 88.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? 62.85 93.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -156.36 127.71 7.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -76.51 132.19 39.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.79 -63.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.843 0.354 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.07 112.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.83 125.13 50.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.59 -30.66 0.2 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.523 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m 51.64 45.33 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.589 HG21 ' H ' ' B' ' 110' ' ' ILE . 6.8 t -103.45 -13.63 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 50.89 82.03 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.03 92.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.25 -64.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.589 ' H ' HG21 ' B' ' 106' ' ' THR . 2.9 mt -71.5 -57.8 4.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.587 0.708 . . . . 0.0 111.154 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.6 Cg_endo -69.77 -5.91 17.35 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.748 2.298 . . . . 0.0 112.306 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 2.8 p -50.52 -27.9 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.046 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -64.06 -49.38 72.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.03 -32.51 74.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.914 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -51.34 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.712 HD11 HG22 ' B' ' 112' ' ' VAL . 36.4 mt -62.69 -37.93 80.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.162 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.691 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.7 OUTLIER -64.19 -56.0 17.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.972 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.34 -48.1 55.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.05 -52.36 64.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.694 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.8 t -60.78 -31.21 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.691 HG23 ' O ' ' B' ' 117' ' ' LEU . 90.1 t -71.07 -58.19 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.643 HG22 HG22 ' A' ' 22' ' ' VAL . 89.9 t -51.58 -57.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.37 -48.73 67.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.549 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.523 ' O ' HD12 ' B' ' 128' ' ' ILE . 44.4 tp -51.76 -61.5 2.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 121' ' ' VAL . 47.9 t -51.52 -31.68 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.28 62.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -66.97 -34.61 78.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.523 HD12 ' O ' ' B' ' 124' ' ' LEU . 3.4 mt -84.84 -39.58 14.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.17 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.58 -61.12 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 61.66 14.82 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -71.44 -58.13 3.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.959 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -61.87 -26.62 68.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.07 -21.3 31.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -90.97 -8.4 49.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.74 14.78 9.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.929 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -46.77 88.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? 63.11 94.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.55 128.07 7.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.921 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -75.93 131.81 39.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.845 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -62.92 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' HG23 ' A' ' 2' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.861 0.362 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -168.98 177.39 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.17 158.65 1.08 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.14 33.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.445 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -51.63 -41.97 61.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.897 0.38 . . . . 0.0 111.126 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.578 HG22 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -67.11 114.71 6.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.28 152.33 20.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.67 24.69 7.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 HG22 ' A' ' 6' ' ' THR . 0.2 OUTLIER -99.88 -59.17 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.851 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -68.39 -57.15 9.13 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.598 0.713 . . . . 0.0 111.1 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.8 Cg_endo -69.78 -2.7 10.64 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.617 2.211 . . . . 0.0 112.368 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.5 p -48.88 -29.15 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.32 -49.31 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.23 -33.19 75.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.21 -50.77 20.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.82 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.732 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.4 mt -65.11 -38.89 83.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.159 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.0 -56.98 13.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.694 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.34 -48.26 62.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.083 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.82 -53.1 43.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 27.4 t -54.36 -51.56 47.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 25' ' ' VAL . 64.4 t -58.07 -47.84 85.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 18' ' ' ALA . 97.8 t -53.82 -63.48 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.159 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.94 62.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 25' ' ' VAL . 1.3 tm? -52.53 -60.48 3.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.34 . . . . 0.0 110.905 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 24' ' ' LEU . 98.3 t -58.48 -37.91 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -26.86 67.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.093 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -77.16 -47.21 20.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.545 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.72 -32.13 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.03 -58.22 3.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.1 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' B' ' 133' ' ' TRP . 14.1 t80 -53.5 -28.15 29.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -68.98 -58.77 3.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.959 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.75 -23.67 53.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.456 ' CG ' ' CE1' ' B' ' 130' ' ' PHE . 20.5 m95 -81.98 -19.48 40.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -81.12 -9.2 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.88 8.45 6.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.25 90.3 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.0 -174.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.26 -177.88 6.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -162.41 31.88 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 61.02 175.02 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.913 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.54 ' O ' HG23 ' B' ' 102' ' ' THR . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.884 0.373 . . . . 0.0 110.842 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.54 HG23 ' O ' ' B' ' 101' ' ' MET . 0.2 OUTLIER -169.2 177.39 4.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.03 158.58 1.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.14 33.76 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.464 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 3.6 t -51.66 -42.01 61.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 111.127 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.575 HG22 HD23 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -67.3 114.84 6.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.25 152.29 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.56 24.77 7.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.575 HD23 HG22 ' B' ' 106' ' ' THR . 0.2 OUTLIER -99.93 -59.07 1.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.928 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 0.8 OUTLIER -68.54 -57.17 8.81 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.59 0.709 . . . . 0.0 111.089 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.9 Cg_endo -69.73 -2.84 10.84 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.69 2.26 . . . . 0.0 112.379 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -48.75 -29.04 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.189 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.45 -49.43 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.29 -33.02 74.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 22.9 t -73.36 -50.64 20.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.748 ' O ' HG23 ' B' ' 120' ' ' VAL . 53.6 mt -65.37 -38.68 83.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.96 -57.23 12.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.693 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -51.11 -48.49 61.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.096 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.56 -53.11 41.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.748 HG23 ' O ' ' B' ' 116' ' ' ILE . 27.2 t -54.43 -51.45 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.201 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.445 ' O ' HG23 ' B' ' 125' ' ' VAL . 65.2 t -58.27 -47.71 86.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.693 HG23 ' O ' ' B' ' 118' ' ' ALA . 96.8 t -53.96 -63.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.084 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.63 -51.05 61.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.484 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.543 HD13 ' N ' ' B' ' 125' ' ' VAL . 1.4 tm? -52.36 -60.58 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.543 ' N ' HD13 ' B' ' 124' ' ' LEU . 97.4 t -58.33 -38.13 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.64 67.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.051 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -77.23 -47.33 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.947 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.536 HD13 HD22 ' B' ' 124' ' ' LEU . 1.8 mp -73.6 -31.97 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.92 -59.14 2.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.097 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 33' ' ' TRP . 13.3 t80 -53.05 -29.04 27.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.941 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -69.22 -60.42 2.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.948 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -59.36 -25.29 64.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.813 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 30' ' ' PHE . 20.3 m95 -86.45 -14.71 42.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -75.71 -28.86 58.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.883 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 172.93 -30.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.81 91.16 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.14 -175.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.92 -175.89 5.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.971 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -160.94 31.31 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 8.6 mttt 60.25 175.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.87 0.367 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.42 117.49 3.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.132 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.9 mtt-85 -121.31 179.68 4.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.94 -66.39 0.56 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m 64.1 45.21 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.862 0.363 . . . . 0.0 111.064 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.4 p -89.01 -46.78 8.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.155 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.41 112.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.85 25.45 14.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.843 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.3 -42.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 4.7 mt -69.42 -57.27 7.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.541 0.686 . . . . 0.0 111.113 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.0 Cg_endo -69.72 -45.98 1.41 Allowed 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.662 2.242 . . . . 0.0 112.414 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 16' ' ' ILE . 4.6 p -51.29 -28.28 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.108 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -49.58 69.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.26 -29.47 69.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.846 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -74.92 -50.52 16.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.688 ' CD1' HG22 ' A' ' 12' ' ' VAL . 49.6 mt -66.47 -38.18 81.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.141 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -68.15 -56.08 10.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.697 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.4 -44.1 54.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.072 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.24 -58.36 8.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.695 HG12 HD12 ' A' ' 24' ' ' LEU . 46.6 t -52.66 -35.16 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 17' ' ' LEU . 86.2 t -72.4 -50.81 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.842 HG22 HG22 ' B' ' 122' ' ' VAL . 87.2 t -51.76 -58.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.141 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.56 -56.24 26.38 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.472 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.733 ' O ' HD12 ' A' ' 28' ' ' ILE . 41.4 mt -50.92 -61.73 2.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.943 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 21' ' ' VAL . 67.8 t -53.59 -32.06 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.127 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' HB2' ' CH2' ' B' ' 133' ' ' TRP . . . -73.23 -32.77 64.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.103 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' B' ' 137' ' ' LYS . 60.4 t80 -73.61 -34.37 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.733 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -84.24 -54.27 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.122 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.45 -61.12 2.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' B' ' 133' ' ' TRP . 22.0 t80 -44.73 -58.98 2.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -37.91 64.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.96 -26.02 64.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -21.1 29.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.21 -45.29 13.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -67.23 -26.67 66.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.5 103.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.875 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.57 169.46 17.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 61.62 99.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -175.67 177.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -179.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.91 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.32 116.86 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.158 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 41.0 mtt-85 -121.88 179.99 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.53 -66.61 0.56 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.487 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 1.3 m 63.92 45.44 4.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.86 0.362 . . . . 0.0 111.124 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 1.4 p -88.97 -46.74 8.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.24 112.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 63.91 25.45 13.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.939 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.29 -41.81 0.88 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.549 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 4.6 mt -69.47 -57.19 7.24 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.642 0.734 . . . . 0.0 111.108 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.1 Cg_endo -69.71 -46.42 1.25 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.735 2.29 . . . . 0.0 112.352 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.712 HG22 HD11 ' B' ' 116' ' ' ILE . 4.8 p -50.97 -28.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -49.42 74.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -31.73 72.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -73.06 -49.61 27.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.715 ' O ' HG23 ' B' ' 120' ' ' VAL . 33.4 mt -62.24 -33.98 61.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.527 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -67.03 -58.52 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.694 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.04 -43.04 50.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.055 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -57.71 11.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.117 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.715 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.4 t -53.59 -35.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.107 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.1 t -72.05 -51.39 31.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.175 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.842 HG22 HG22 ' A' ' 22' ' ' VAL . 94.2 t -51.35 -58.96 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.7 -56.28 25.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.497 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.747 ' O ' HD12 ' B' ' 128' ' ' ILE . 40.7 mt -50.96 -61.99 1.89 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.824 0.345 . . . . 0.0 110.905 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.493 HG23 ' O ' ' B' ' 121' ' ' VAL . 76.0 t -52.67 -31.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.93 -30.97 61.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.09 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -79.03 -35.48 42.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.747 HD12 ' O ' ' B' ' 124' ' ' LEU . 2.9 mp -83.4 -63.44 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.055 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 125' ' ' VAL . . . -55.48 -62.22 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 10.3 t80 73.64 -59.41 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.28 -35.24 64.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.906 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -24.68 47.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . 0.535 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 0.7 OUTLIER -84.64 -22.57 29.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.83 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . 0.485 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -86.62 -46.69 9.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.87 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 3.2 m -68.12 -26.11 65.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.9 103.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.889 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 27' ' ' TYR . 0.3 OUTLIER -137.17 169.24 18.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 61.24 99.35 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.955 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -175.51 177.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -179.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.926 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.828 0.347 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.9 p -118.38 142.65 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -162.33 -177.63 5.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.56 156.31 4.57 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.56 ' HB ' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -54.4 158.99 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.378 . . . . 0.0 111.121 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -172.93 2.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 63.34 104.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 62.99 22.62 13.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.81 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.56 HD13 ' HB ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -124.18 -73.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 1.2 mp -72.46 -57.87 3.26 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.591 0.71 . . . . 0.0 111.109 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 54.2 Cg_endo -69.71 -5.68 16.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.655 2.237 . . . . 0.0 112.381 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 16' ' ' ILE . 3.4 p -50.07 -28.3 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.194 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -68.75 -49.94 54.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 t -64.02 -32.23 73.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.829 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.5 m -73.24 -52.84 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.71 ' O ' HG23 ' A' ' 20' ' ' VAL . 45.7 mt -65.5 -36.55 77.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.094 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 18' ' ' ALA . 5.5 tt -65.27 -57.25 8.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.957 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.52 -49.13 56.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.05 -53.03 56.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 16' ' ' ILE . 63.4 t -54.51 -53.12 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.98 -51.86 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 18' ' ' ALA . 69.2 t -49.49 -58.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.34 -33.44 58.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.487 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.456 ' HA ' HD13 ' A' ' 24' ' ' LEU . 0.5 OUTLIER -61.28 -54.5 43.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.867 0.365 . . . . 0.0 110.976 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.17 -32.75 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.76 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -76.64 -45.2 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.85 -53.58 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -51.81 -61.22 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -52.43 -29.99 27.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -75.97 -36.96 59.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -63.91 -38.63 91.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.485 ' CD2' ' CZ ' ' B' ' 130' ' ' PHE . 1.5 m-90 -86.79 -16.03 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -58.5 -45.87 87.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.7 t -147.1 -40.9 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.64 156.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.73 75.38 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.04 -39.5 92.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.9 95.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.68 166.38 33.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.837 0.351 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 43.3 p -118.19 142.88 46.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 26.9 ptt-85 -162.08 -177.83 6.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.64 156.02 4.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.453 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.541 ' HB ' HD13 ' B' ' 109' ' ' LEU . 0.1 OUTLIER -54.4 159.27 2.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.878 0.37 . . . . 0.0 111.162 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.84 -173.0 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.098 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.33 105.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.823 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 63.12 22.68 13.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.541 HD13 ' HB ' ' B' ' 105' ' ' THR . 0.1 OUTLIER -124.36 -73.4 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.922 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.526 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 1.2 mp -72.66 -57.76 3.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.596 0.712 . . . . 0.0 111.149 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.0 Cg_endo -69.91 -5.47 16.37 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.588 2.192 . . . . 0.0 112.345 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.548 HG22 HD11 ' B' ' 116' ' ' ILE . 3.5 p -49.98 -28.47 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -67.82 -50.29 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -32.65 74.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.819 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 17.7 m -69.95 -53.43 17.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.729 ' O ' HG23 ' B' ' 120' ' ' VAL . 47.0 mt -60.98 -32.64 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -64.29 0.9 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.669 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -48.41 -45.94 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -54.22 37.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.729 HG23 ' O ' ' B' ' 116' ' ' ILE . 57.6 t -54.9 -52.57 41.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.137 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 22' ' ' VAL . 59.9 t -57.88 -44.08 85.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.669 HG23 ' O ' ' B' ' 118' ' ' ALA . 53.8 t -56.5 -63.95 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.142 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.21 95.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.485 HD13 ' N ' ' B' ' 125' ' ' VAL . 1.9 tm? -58.21 -61.83 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.485 ' N ' HD13 ' B' ' 124' ' ' LEU . 88.1 t -57.13 -33.46 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.059 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.64 -25.15 60.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -77.06 -45.86 25.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.466 HD11 HD21 ' B' ' 124' ' ' LEU . 9.0 mt -74.77 -53.98 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.0 -61.16 2.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.114 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 33' ' ' TRP . 20.4 t80 -51.95 -30.05 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -76.16 -37.07 58.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -63.74 -38.44 91.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -87.31 -2.04 58.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -51.9 -32.89 34.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 22.1 t -125.27 -36.25 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.39 156.6 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.13 75.3 1.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.03 92.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.99 95.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.873 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.05 166.32 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.794 0.33 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.99 179.55 6.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -64.14 -26.65 68.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.81 10.14 21.63 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.496 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m 51.39 80.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.156 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.65 -72.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.143 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 54.26 24.3 4.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.556 ' O ' HD12 ' A' ' 9' ' ' LEU . 1.2 m-20 -168.87 27.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 8' ' ' ASN . 2.3 mp -149.19 -68.67 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 3.0 mt -70.23 -57.97 5.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.559 0.695 . . . . 0.0 111.129 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.3 Cg_endo -69.76 -35.97 11.66 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.734 2.289 . . . . 0.0 112.304 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 16' ' ' ILE . 2.7 p -55.76 -21.89 11.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -72.74 -49.78 28.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -27.48 67.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.8 m -77.14 -51.5 10.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.691 ' O ' HG23 ' A' ' 20' ' ' VAL . 51.9 mt -67.18 -40.56 85.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -65.5 -55.25 18.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -50.45 -47.82 56.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.169 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.07 -56.54 18.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 16' ' ' ILE . 43.5 t -53.15 -35.01 22.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.139 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 17' ' ' LEU . 99.7 t -73.36 -45.91 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.958 HG22 HG22 ' B' ' 122' ' ' VAL . 57.8 t -55.1 -59.33 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.143 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.495 ' HA2' ' CE3' ' B' ' 133' ' ' TRP . . . -59.79 -51.45 58.92 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.707 ' O ' HD12 ' A' ' 28' ' ' ILE . 55.1 tp -51.7 -61.94 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.377 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 21' ' ' VAL . 70.2 t -54.25 -34.52 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.166 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.04 -29.72 65.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -75.82 -35.06 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.98 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.707 HD12 ' O ' ' A' ' 24' ' ' LEU . 2.9 mp -81.06 -45.42 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.125 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.92 -61.18 2.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -44.76 -54.84 5.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.1 -44.19 95.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.3 ttt-85 -59.78 -26.26 65.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -86.53 -17.56 33.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -66.95 -37.61 84.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.9 -34.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.43 103.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 175.52 9.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.915 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.02 86.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -158.63 82.96 0.82 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.67 164.43 23.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 179.888 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.888 0.375 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.81 178.66 7.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.145 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.19 -27.14 68.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 10.66 21.47 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.545 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 3.3 m 53.41 79.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 111.117 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.427 HG21 HD12 ' B' ' 110' ' ' ILE . 0.2 OUTLIER -162.0 -74.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 54.24 21.8 3.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . 0.675 ' C ' HD12 ' B' ' 109' ' ' LEU . 1.1 m-20 178.62 30.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.675 HD12 ' C ' ' B' ' 108' ' ' ASN . 6.5 mp -141.66 -58.77 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.929 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 3.0 mt -73.04 -58.2 2.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.695 0.759 . . . . 0.0 111.159 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 54.3 Cg_endo -69.74 -38.25 8.1 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.639 2.226 . . . . 0.0 112.324 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.677 HG22 HD11 ' B' ' 116' ' ' ILE . 4.4 p -52.69 -26.69 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -66.45 -49.46 66.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -30.73 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 52.8 m -73.66 -50.52 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.725 ' O ' HG23 ' B' ' 120' ' ' VAL . 41.1 mt -61.62 -35.93 70.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.128 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.435 ' O ' HG23 ' B' ' 121' ' ' VAL . 0.4 OUTLIER -65.76 -56.88 9.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.756 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -50.19 -47.26 54.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.072 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.74 -56.5 18.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.146 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 116' ' ' ILE . 46.0 t -52.53 -35.67 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.483 ' O ' HG23 ' B' ' 125' ' ' VAL . 93.8 t -73.53 -44.92 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.958 HG22 HG22 ' A' ' 22' ' ' VAL . 61.0 t -55.36 -59.88 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.141 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.11 -50.17 70.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.722 ' O ' HD12 ' B' ' 128' ' ' ILE . 57.2 tp -53.19 -62.41 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 110.917 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 121' ' ' VAL . 65.9 t -54.77 -36.1 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.079 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.95 -25.65 62.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -79.71 -33.54 40.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.722 HD12 ' O ' ' B' ' 124' ' ' LEU . 2.9 mp -76.76 -63.8 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.11 -64.78 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . . . . . . . . . 3.0 t80 71.77 -62.03 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.48 -42.53 87.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.882 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -56.96 -24.09 50.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . 0.495 ' CE3' ' HA2' ' A' ' 23' ' ' GLY . 2.8 m95 -99.14 -9.69 23.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.84 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -60.46 -31.7 70.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.895 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.37 -34.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.5 103.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.846 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.86 174.57 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.892 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.83 86.41 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -158.54 83.1 0.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.54 164.27 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.951 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.21 137.78 44.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.195 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -154.15 127.71 8.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.1 35.01 1.95 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.474 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.7 p -59.6 -171.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.13 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.604 ' CG2' HD22 ' A' ' 9' ' ' LEU . 0.3 OUTLIER 64.42 104.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -94.0 141.27 28.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.33 16.22 9.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD22 ' CG2' ' A' ' 6' ' ' THR . 2.3 mp -121.91 -73.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.2 mt -70.56 -57.66 5.28 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 0.0 111.095 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 10' ' ' ILE . 53.8 Cg_endo -69.79 -4.59 14.36 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.63 2.22 . . . . 0.0 112.36 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.624 HG22 HD11 ' A' ' 16' ' ' ILE . 3.4 p -49.37 -28.94 3.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -60.32 -46.86 88.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -40.74 91.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -46.08 78.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.791 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.724 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.3 mt -63.27 -46.44 95.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.152 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 8.2 tp -53.76 -60.2 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 22' ' ' VAL . . . -51.04 -50.05 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.95 -50.64 63.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.044 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 16' ' ' ILE . 47.8 t -58.04 -51.52 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.7 t -57.81 -48.34 83.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.175 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 18' ' ' ALA . 85.1 t -53.68 -63.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.44 -51.78 56.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.544 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.56 HD22 HD13 ' A' ' 28' ' ' ILE . 1.3 tm? -52.0 -60.59 3.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 110.955 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.556 ' N ' HD13 ' A' ' 24' ' ' LEU . 94.2 t -58.22 -38.05 66.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.99 67.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -77.02 -47.31 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.56 HD13 HD22 ' A' ' 24' ' ' LEU . 1.8 mp -73.5 -32.22 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.03 -61.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -54.62 -30.25 54.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -80.29 -51.73 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.03 -36.79 51.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.625 ' HB3' ' CE1' ' B' ' 130' ' ' PHE . 5.9 m0 -86.07 -20.92 28.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.26 -45.26 49.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 m -69.97 -26.42 64.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 -40.01 61.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.803 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.59 -178.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 55.26 57.85 5.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.09 170.65 16.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.08 140.11 32.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 1.9 mtp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.832 0.349 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.11 138.09 45.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.132 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -154.16 127.26 8.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.05 34.44 1.93 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.477 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 29.2 p -59.63 -171.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.881 0.372 . . . . 0.0 111.141 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' THR . . . . . 0.683 HG22 ' HB2' ' B' ' 109' ' ' LEU . 0.2 OUTLIER 61.71 104.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.166 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -100.1 135.1 42.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.18 14.87 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.683 ' HB2' HG22 ' B' ' 106' ' ' THR . 9.4 mp -118.13 -56.51 2.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.929 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' B' ' 111' ' ' PRO . 5.2 mt -70.32 -57.61 5.65 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 0.0 111.181 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' B' ' 110' ' ' ILE . 53.2 Cg_endo -69.82 -5.17 15.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.636 2.224 . . . . 0.0 112.316 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.687 HG22 HD11 ' B' ' 116' ' ' ILE . 3.0 p -49.46 -29.26 3.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.44 -49.6 75.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.967 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' CYS . . . . . 0.495 ' HA ' ' CD2' ' B' ' 117' ' ' LEU . 0.1 OUTLIER -68.72 -42.04 78.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.857 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -37.52 85.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.687 HD11 HG22 ' B' ' 112' ' ' VAL . 45.0 mt -75.24 -55.29 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.651 ' O ' HG23 ' B' ' 121' ' ' VAL . 3.5 pp -58.48 -39.34 79.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.644 ' O ' HG23 ' B' ' 122' ' ' VAL . . . -64.92 -50.57 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.47 68.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 116' ' ' ILE . 41.7 t -63.14 -51.33 72.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' VAL . . . . . 0.651 HG23 ' O ' ' B' ' 117' ' ' LEU . 93.6 t -57.71 -48.73 82.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.644 HG23 ' O ' ' B' ' 118' ' ' ALA . 97.3 t -53.55 -63.49 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.37 -51.77 56.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.56 HD13 ' N ' ' B' ' 125' ' ' VAL . 1.3 tm? -51.83 -60.74 2.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.903 0.382 . . . . 0.0 110.93 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.56 ' N ' HD13 ' B' ' 124' ' ' LEU . 99.8 t -58.12 -38.04 65.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.118 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.38 -26.92 67.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -76.99 -47.29 21.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.542 HD13 HD22 ' B' ' 124' ' ' LEU . 1.8 mp -73.79 -31.96 33.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.116 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.31 -60.63 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.625 ' CE1' ' HB3' ' A' ' 33' ' ' TRP . 12.4 t80 -52.39 -30.61 29.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -80.06 -50.77 9.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.904 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.44 -36.58 54.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -85.57 -21.22 28.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -74.41 -45.3 47.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.897 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -70.1 -26.59 64.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -39.41 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.84 -178.97 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 55.24 57.39 5.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -78.46 170.76 16.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.95 140.04 32.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.907 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.923 179.836 . . . . . . . . 1 1 . 1 stop_ save_